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ABSTRACT 
 
Background 
HIV has reached epidemic proportions globally with Sub-Saharan Africa carrying the greatest 
burden (71%). It is estimated that there are 37 million people world-wide infected with HIV, 
and an estimated 6.8 million live in South Africa. Globally there were 2.1 million adolescents 
living with HIV in 2014.   
Improved access to Antiretrotiviral Therapy (ART) has led to a steep decline in HIV 
incidence and HIV-related mortality. Yet despite these successes in terms of HIV treatment 
outcomes, HIV-related mortality amongst adolescents has increased. Adolescents are defined 
by the WHO as individuals between 10 and 19 years old. WHO states that adolescents have 
poorer access to ART, are at a higher risk of disengaging from care and have special needs to 
keep them motivated to remain in care. The uptake of adolescents into the South African 
ART programme is low and those that are enrolled into the programme have poorer 
adherence than their adult counterparts.  
 
Aim 
The aim of the study was to explore the factors that influence adherence to ART amongst 
adolescents in a primary health care clinic in a low socio-economic, urban setting in Cape 
Town.  
 
Methodology 
An exploratory qualitative design was employed where data was collected through two key 
informant interviews with staff from an urban primary health care clinic.  Four focus group 
discussions and eight individual in-depth interviews were held with adolescents and young 
people who accessed ART at this health facility. Audio data was digitally recorded and 
transcribed verbatim.  Data was analyzed using content analysis. 
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Results 
The study identified school commitments, strained teacher-pupil relationships, negative 
household dynamics and ill-treatment by non-biological caregivers as major reported barriers 
to adherence. In addition, poor service delivery, missing and misplaced files and long waiting 
times came under major criticism. Fear of intended or unintended disclosure of HIV status, 
perceived stigma and discrimination, treatment fatigue and having unstructured lives, 
profoundly influenced ART adherence. Finally, having a strong support system, disclosing to 
a trustworthy person and having goals and ambitions served as motivators to remain adherent 
to ART. 
 
Conclusions 
This study highlighted the complexity of ART adherence amongst this age group due to 
school factors, social factors, health services factors, therapy related factors and patient 
factors. Interventions to improve adherence should aim to address treatment fatigue, 
disclosure, household dynamics, service delivery factors, as well as the impact of school 
commitments and symptoms of depression on ART adherence amongst adolescents. 
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CHAPTER ONE 
INTRODUCTION 
1.1 BACKGROUND 
HIV has reached epidemic proportions globally with Sub-Saharan Africa carrying the 
greatest burden (71%) (World Health Organization [WHO], 2015). WHO (2015) estimates 
that there are 37 million people world-wide infected with HIV and an estimated 6.8 million 
live in South Africa. Globally there are 2.1 million adolescents living with HIV (WHO, 2015) 
with the majority (58%) of these being female (Idele et al., 2014). Nearly one sixth of all new 
infections occur between 15 and 19 years old (Davies & Pinto, 2015). Idele et al. (2014:145) 
suggest that globally “…about 830 adolescents were infected with HIV everyday of 2012”. 
The burden of adolescent HIV incidence has attracted the attention of the International AIDS 
Society (IAS) and one of the objectives of the recently held 21
st
 International World AIDS 
Conference in Durban was the promotion “…of HIV responses that are supported by and 
tailored to the needs of at risk populations or people living with HIV [PLHIV], 
including…young people” (IAS, 2016:4).  
 
The progression of HIV disease can be reversed with strict adherence to a complex regimen 
of highly active antiretroviral treatment (HAART). HAART became publicly available in 
South Africa in 2004 following the approval of the Operational Plan for Comprehensive HIV 
and AIDS Care, Management and Treatment for South Africa by the Cabinet in November 
2003 (Simelela & Venter, 2014). The aim of this plan was that HIV positive patients with a 
CD4 count of less than 200 should be able to access ART at no charge from an accredited 
public sector health facility from each one of the country’s districts. As a result the “first 
generation of peri-natally infected children is now entering adolescence” (Cotton et al., 
2010:751). 
 
Improved access to HAART has led to a steep decline in HIV incidence and HIV-related 
mortality (WHO, 2015). Yet despite these successes in terms of HIV treatment outcomes, 
HIV-related mortality amongst adolescents has increased. Adolescents are defined by the 
WHO as individuals between the ages of 10 and 19 years (WHO, 2013). It is only amongst 
the adolescent age-group in which AIDS-related deaths are increasing (Davies & Pinto, 
2015). WHO (2013) has identified that mortality amongst adolescents has increased globally 
by about 50% between 2005 and 2012. Reports by WHO (2015) and The Joint United 
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Nations Programme on HIV/AIDS [UNAIDS] (2015) have identified HIV as being the 
second leading cause of mortality amongst adolescents globally. Furthermore, HIV-related 
deaths amongst adolescents have tripled since 2000 (UNAIDS, 2015). WHO (2013) argues 
that the reason for this statistic is primarily due to insufficient prioritization of adolescent 
health in national health programmes, poor provision of appropriate HIV testing and 
counselling (HCT) services and substandard follow-up care for adolescents who test HIV 
positive and who require HAART. Furthermore the report states that adolescents have poorer 
access to HAART, are at a higher risk of disengaging from care and have special needs to 
keep them motivated to remain in care (WHO, 2015). In addition, the Global Burden of 
Diseases Study 1990 - 2013, found that HIV/AIDS, road injuries and drowning were the 
leading causes of death for adolescents between 10 and 14 years old (Mokdad et al., 2016). 
 
The uptake of adolescents into the South African ART programme is low and those that are 
enrolled into the programme have poorer adherence than their adult counterparts (Hislop, 
Maartens & Nachega, 2009; WHO, 2015). A South African survey found that relative to 
other age groups, less than 50% of adolescents who require HAART are on treatment (Davies 
& Pinto, 2015). It is argued that a unique approach is necessary in the management of 
adolescents on HAART because adolescence is a transitional period. These transitions occur 
on physiological, psychological and intellectual levels (Cotton, Jaspan, Li, Nattrass, O’Brien 
& Rabie, 2010).  The changes that accompany these transitions can be very stressful to both 
the adolescent and his /her family and caregivers. In addition, the usual stressors experienced 
by adolescents may be compounded by the psycho-social dynamics associated with HIV as a 
disease such as stigma, discrimination and structural deprivations. Adolescents are thus likely 
to experience very unique challenges with regards to ART adherence. The management of 
adolescents on HAART has to take cognizance of the complexity of biological and 
psychosocial changes and developments which take place in the life of adolescents (Bekker, 
Johnson, Wallace & Hosek, 2016).  
 
Local and international data do not accurately estimate uptake of ART among the adolescent 
group because routine data are not captured/reported separately for adolescents. This is 
because patients younger than 15 years are considered paediatric patients and those older than 
15 years are considered adult patients. We do however know that HIV incidence is the 
highest in the 15-24 year old age group (UNAIDS, 2013). UNAIDS (2014:14) recommends 
“… enhanced age-disaggregated data collection and reporting, as well as development of 
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robust surveillance strategies to monitor trends and outcomes for children and adolescents”. 
Idele et al. (2014) also assert that in order to improve health outcomes of adolescents, 
enhancement of routine data collection, analysis and reporting on adolescents are essential. 
 
Optimal adherence to a specified antiretroviral regimen is crucial to ensure that the patient 
achieves virological suppression (avoids viral replication) and remains virologically 
suppressed. There is a close association between reported non-adherence and viral load. 
Maskew, Bor, Maclead, Carmona, Sherman and Fox (2016) reported that the National Health 
Laboratory Services (NHLS) database revealed declining virological suppression amongst 
adolescents in the public sector since 2004. Significant and consistent motivation is thus 
necessary for HIV positive adolescents on ART to persist on a life-long ART regimen. 
Bekker, Cotton, Maarten, Meyers, Venter and Wilson (2008) acknowledge that optimal 
adherence for HIV treatment (ART) is set significantly higher than for other chronic diseases, 
which makes it even more difficult to achieve. 
 
Non- or poor adherence to ART is the most significant challenge in ensuring patients remain 
virologically suppressed (Malee & Mellins, 2013). Non-adherence can be due to a number of 
factors. Malee and Mellins propose that the barriers to adherence may be patient-related, 
structural, provider-related, disease-related, medication-related or psychological barriers. 
WHO (2015) and UNAIDS (2014) further assert that other factors such as the legal age of 
consent, policies and parental consent laws are barriers to accessing ART by adolescents  and 
remaining adherent. The factors leading to non-adherence may change over time and as such 
adherence needs to be monitored longitudinally and dynamic approaches sought to address 
patterns of non-adherence (Larkan, van Wyk, Stevens & Saris, 2015). 
 
1.2 PROBLEM STATEMENT 
Adolescents face very unique challenges on both physiological and psychosocial levels. In 
addition, adherence to ART in itself is a complex problem. The factors associated with sub-
optimal adherence to ART among adolescents in Sub-Saharan Africa have not been 
adequately explored (Gross et al., 2013). In the Western Cape province no previous research 
into adherence to ART amongst adolescents has been done. The current research explores 
cultural and context-specific issues pertaining to adherence to ART amongst adolescents.  
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1.3 OUTLINE OF MINI-THESIS 
This qualitative research enquiry will be presented in the following order: 
Chapter 1: Introduction  
Chapter 2: Literature Review  
Chapter 3: Research Methodology 
Chapter 4:  Presentation of Results  
Chapter 5: Discussion of Results  
Chapter 6: Conclusions, recommendations, suggestions for further research and the strengths 
and limitations of the study.  
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 INTRODUCTION  
WHO (2013) classifies the barriers to ART adherence as: socio-economic, health care team- 
and system-related, therapy-related and patient-related factors. I will explain each one of 
these factors in turn.  
 
2.2 SOCIO-ECONOMIC FACTORS 
Many factors in the social and economic environment of adolescents have the potential to 
impact on their health and health-seeking behavior, and in this particular case, their 
adherence to ART. WHO found that adolescents remain socially and economically vulnerable 
to HIV (2013). This first section will discuss how various elements in the social and 
economic surroundings of patients may impact on ART adherence. I will discuss the impact 
of the school sector on adherence as well as the role of financial support and household 
factors. 
 
2.2.1 School sector 
The education and employment sectors play an important role in access to HIV care and 
remaining in care (UNAIDS, 2013). These two sectors have the potential to form strong and 
important links to the health care system. At school, learners can be taught in an evidence-
informed yet culturally sensitive manner about HIV and the importance of remaining in HIV 
care (Davies & Pinto, 2015). However, not all studies have found an association between 
adherence and being less educated or not being part of the formal education system (Chesney, 
2000).  
 
Chesney (2000) proposes that health care providers may be over-emphasizing the influence 
of education on adherence as it made no difference in adherence in their cohort. Williams et 
al. (2006) found that repeating a grade in school may in fact be associated with marginally 
decreased adherence. This may be particularly important since some HIV positive 
adolescents may suffer cognitive delay (Reisner, Mimiaga, Skeer, Perkovich, Johnson & 
Safren, 2009). HIV positive youth can have specific neurocognitive problems such as poorer 
executive function when compared to their HIV negative counterparts, and experience 
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problems with inhibition and cognitive flexibility (Hoare, 2016). Hoare argues that good 
executive functioning is necessary to cope with daily activities, which, in the case of an 
adolescent may include dealing with the intellectual demands of school.  Neurocognitive 
impairment could thus lead to failing a grade in a mainstream school which could lead to 
poor adherence (Williams et al., 2006). This casts some doubt on the positive impact of main 
stream schooling on adherence since optimal cognition for academic progress in school is 
essential in South Africa. 
 
2.2.2 Financial support 
Cluver et al. (2016) suggest that financial support may be important for adults on ART. This 
type of support may include, amongst others, government grants or food security. Cotton et 
al. (2010), report from their qualitative enquiry with 26 HIV positive adolescents from 
communities with low socio-economic status in the Western Cape province, that participants 
felt their lives would be significantly improved if they received support in the form of food or 
money. All participants in this study knew their HIV status with the majority having been 
peri-natally infected. WHO (2013) also argues that social and financial support is critical to 
assist HIV positive adolescents. For example, financial support will enable adolescents who 
live far from the health facility to access health facilities. It will also enable them to purchase 
nutritional food that will contribute towards keeping them healthy.  
 
UNAIDS (2013) recommends that social-protection programs should be “HIV sensitive” and 
should include access to quality HIV care and treatment, access to good education and 
economic support. The impact of financial support was also explored by Boyes, Cluver, 
Orkin and Sherr (2014). The authors argue that “structural deprivation increases HIV risk by 
increasing psychosocial problems” (Boyes et al., 2014:13). Cluver et al. (2015:20260) 
further argue that “…social and structural deprivation is negatively impacting adolescents’ 
capacity to protect themselves and others”. Bekker et al. (2015) suggest that cash incentives 
may encourage safer sex practices and reduce economic vulnerability to HIV and its 
repercussions. Bermudez, Jennings, Ssewamala, Nabunya, Mellins and McKay (2016) found 
that Ugandan adolescents with a greater economic advantage had a higher chance of 
remaining adherent to ART. Hudelson and Cluver (2015) and McPherson et al. (2015) assert 
that further exploration is required of precisely how financial incentives relate to ART 
adherence.  
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Cluver et al. (2016:79) report from their cross-sectional study of adolescents receiving 
HAART in the Eastern Cape that “cash plus care” was associated with increased adherence to 
ART over the recent short term (past 7 days). Examples of cash support may be government 
welfare grants or food security whereas types of care initiatives may be being part of a HIV 
support group or receiving good parenting.  An example of a cash and care initiative may 
thus be receiving a government grant and good parenting concurrently. They recommend that 
a combination of different support interventions may be more successful in reducing non-
adherence than an isolated intervention. Thus, financial support on its own may provide 
welcome relief to HIV positive adolescents but when combined with other forms of support it 
will be more successful in reducing non-adherence. 
 
2.2.3 Household factors 
Household factors may include factors in the home and family environment which could have 
an influence on ART adherence such child-parent/caregiver relationships, sibling 
relationships and family routines. Family support is also associated with adherence to HIV 
care and treatment amongst adolescents. Brown, Lourie and Pao (2000) argue that parenting 
and family dynamics play a greater role in enabling adolescents to adjust to their HIV status 
and that the disease process itself is of lesser significance in the adjustment process. The 
UNAIDS (2014) also contends that parents play a crucial role in the context of HIV as they 
influence their child’s value system,  attitudes and behaviors related to health. Mellins, 
Brackis-Cott, Dolezal and Abrams (2004) found that when controlling for age, 
caregiver/family factors such as poor parent-child communication, poor caregiver quality of 
life, high parent/caregiver stress levels and lower levels of disclosure were the most strongly 
associated with non-adherence. Cotton et al. (2010) confirmed this positive association 
between good parenting/family relationships and adherence to HIV care by adolescents. 
Goode, McMaugh, Crisp, Wales and Ziegler (2003) found that there is an interaction between 
the adolescent’s ART regimen and the family routine. They suggest that the interplay 
between these factors may compound the challenge to optimal adherence. Furthermore, 
Bhana et al. (2016) found that there is an association between good parent-child and other 
family relationships and positive health outcomes of the affected children. Interestingly, 
Williams et al. (2006) and Reisner et al. (2009) found that if the primary caregiver was an 
adult other than the biological parent, then adherence was improved. This could be attributed 
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to the biological parent having medical comorbidities or possible guilt and depression about 
mother to child transmission of HIV (Haberer & Mellins, 2009). 
 
Sharer, Cluver, Shields and Ahearn (2016) found that sibling support was consistently 
associated with good mental health.  They conducted this survey in households that had 
children between the ages of 10 and 17 years old in both rural and urban districts in the 
Western Cape and Mpumalanga. Good mental health, in turn, may have a positive impact on 
adherence. Williams et al. (2006) further suggest that family dynamics and characteristics 
should be assessed prior to initiating HAART to adolescents who acquired HIV infection 
peri-natally so that targeted intervention strategies can be directed towards the household to 
minimize the risk of non- or poor adherence. 
 
2.3 HEALTH CARE TEAM AND SYSTEM-RELATED FACTORS 
Under this heading I will discuss the impact of health care system factors on adherence. This 
section will focus on the impact of transitioning from paediatric to adult health care, having 
adolescent-friendly health services and the impact of drug stock-outs.  
 
2.3.1 Transition from paediatric to adult health care 
As previously mentioned HIV positive clients are broadly classified into paediatric (0-15 
years) - and adult patients (older than 15 years). Adolescents have very unique needs and 
therefore recommendations used for adult and paediatric groups can often not be strictly 
applied to adolescents (WHO, 2013). There is no specific provision made for the needs of 
adolescents and Maskew et al. (2016) suggest that the South African ART programme has no 
official age cut-off for transitioning from paediatric to adult health care.  HIV positive 
adolescents might have received good paediatric care but not be familiar with how the adult 
health care system works. The complexities associated with transition from paediatric to adult 
health care might serve as a barrier to remaining in HIV care (UNAIDS, 2014). These 
complexities may be related to paediatric patients being accustomed to a well-structured 
paediatric clinic and being familiar with certain health care practitioners. In addition they 
may be used to being accompanied to the clinic by a caregiver but during adolescence may be 
expected to go to the health facility on their own. They further argue that the experience of 
adolescents progressing to adult health care in resource-limited settings is minimal and poorly 
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understood. Therefore it needs to be better understood in order to implement strategies to 
facilitate the transitioning process.  Wiener, Kohort, Battles and Pao (2009) argue that there 
may be poor communication between paediatric and adult health care services thus leaving 
the momentous task of explaining their HIV and ART history to the adolescents themselves. 
The adolescent may find it stressful to explain details of their medical history and potentially 
give an inaccurate account of their medical history. This could lead to prescribing an 
incorrect drug regimen which could result in virological failure. Loss of medical 
documents/clinic files may have a similar consequence as important details about the 
patients’ medical history and prior ART exposure may be lost. This too may lead to 
prescribing an incorrect ART regimen which may lead to virological failure or adverse drug 
reactions if medication is prescribed to which the patient is allergic. Whitehouse (2013) 
suggests that good management of medical records is pivotal for continuity of care and that 
problems with medical records are the cause of a high proportion of adverse incidents.  
 
2.3.2 Adolescent-friendly health services 
An understanding relationship has to exist between adolescents and staff members in order to 
facilitate good adherence to ART (Ferrand, 2016). This entails health care workers having 
good attitudes and being responsive to the needs of adolescents. Pontali (2005) also suggests 
that skilled staff is necessary to develop adherence programs which could include integrated 
sexual and reproductive health care as well as being vigilant to the barriers to adherence. This 
begs the question of whether specifically trained adolescent health care staff is necessary to 
look after these clients.  
  
Underwood, Hendrickson, Lynn, Van Lith, Kunda and Mallalieu (2014) found that rigid 
clinic operating times may impede timely ART collection. This could lead to adolescents 
running out of medication when they miss appointments and subsequent bouts/periods of 
poor adherence. Chesney (2000) and Hudelson and Cluver (2015) found that the health care 
system and patient-provider relationships played a significant role in adolescents remaining 
adherent to ART. Cotton et al. (2010) also assert that specialized adolescent clinics which 
carefully consider the needs of adolescents may optimize care delivered to this group of 
people. 
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Ferrand (2016) reports that structural factors such as distance to the clinic, waiting times, 
drug shortages and negative health care worker (HCW) attitudes, are all associated with poor 
adherence. Long distances to the clinic may impede adherence if adolescents do not have the 
financial means to cover transport expenses to the health facility. Furthermore, long waiting 
times at the health facility may discourage them from going for routine follow-up to the clinic 
as they may have other demands on their time such as school commitments. Ferrand also 
reports that good adherence is facilitated by an understanding relationship between the health 
care provider and the patient; health care providers need to be sensitive and responsive to the 
specific needs that HIV positive adolescents have. 
 
2.3.3 Drug stock-outs 
The health facility has to ensure a regular and timeous supply of medication to ensure 
treatment adherence. Reda and Biadgilign (2012) found that an inconsistent supply of ARV 
drugs may severely impact adherence in a negative way. According to a survey done in 2008, 
34% percent of low- and middle income countries experienced ARV drug stock outs (WHO, 
2010, as cited in Reda & Biadgilign, (2012). Medication stock-outs may thus lead to poor 
adherence which could lead to virological failure and other adverse patient outcomes. The 
recent South African National Stop Stock Outs Survey (2015) found that of the 60% of South 
Africa’s public health facilities surveyed, one in four experienced a shortage of ART or TB 
medication at least once during the preceding year.  
 
2.4 THERAPY-RELATED FACTORS 
This section will highlight the impact of the medication itself on adherence. I will discuss 
how the complexity of ART regimens and side-effects of ARV drugs impact on adherence. 
 
2.4.1 Complexity of Antiretroviral treatment regimens  
ART regimens should be as simple as possible after accounting for efficacy and tolerability 
(Nuttal, 2006). Reisner et al. (2009) found an association between a simple ART regimen and 
good adherence. Pontali (2005) also suggests that ART regimens should be tailored to the 
patient’s routine. If possible adolescents should be given a fixed dose combination as the 
simplification of ART regimens impact positively on ART adherence (Nuttall, 2006). A fixed 
dose combination tablet consists of two or more active components in fixed dosages. High 
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rates of non-adherence to ART amongst adolescents highlight the need to make treatment 
regimens simpler and more tolerable (Penazzato et al., 2015).  
 
The current South African Department of Health ART guidelines (2015) make provision that 
all treatment naïve adults and adolescents can be started on a fixed dose regimen of 
Tenofovir, Emtricitabine and Efavirenz. This is assuming that there are no contra-indications 
to any one of these drugs. Peri-natally infected adolescents may be heavily treatment 
experienced and not qualify for the fixed dose combination but their treatment regimens 
should still be simplified where feasible. The South African HIV Clinicians Society (2013) 
advises that reducing the pill burden to one pill once a day has been reported to improve 
adherence but that adherence counselling is still essential. The REACH (Reaching for 
Excellence in Adolescent Care and Health) study also found an association between 
adherence and pill burden (Murphy, Belzer, Durako, Sarr, Wilson & Muenz, 2010). The use 
of other medications such as treatment for co-morbidities and prophylactic treatment can also 
increase the pill burden and this may adversely impact on adherence.  
 
Antiretroviral medications need to be taken every day for the duration of the patient’s life. 
This process may be experienced as tedious by some adolescents. Merzel, Van Devanter and 
Irvine (2008) identified regimen fatigue as a major factor impacting on older adolescents’ 
ability to remain adherent to a treatment regimen. Haberer and Mellins (2009) also found 
treatment fatigue to be common amongst children with chronic diseases. The severe impact 
of treatment fatigue on ART adherence inspired the BREATHER Trial. The BREATHER trial 
examined the potential for drug-free weekends in children, adolescents and young people 
who are on an Efavirenz-based first line ART regimen (Butler et al., 2016). Participants were 
randomised into a continuous seven day regimen group or a five day regimen group with a 
break on weekends. The end result was that a five-day regimen was not inferior to a seven-
day regimen in maintaining viral load suppression. In addition, “…overall reduction in drug 
exposure could reduce long-term toxicity for individuals…” (Butler et al., 2016:9). 
Furthermore, the shorter cycle was found to be beneficial for participants’ social lives. 
Adherence was similar between the two groups but slightly better in the shorter cycle group. 
This was a multi-continent study and the findings of this study should thus be considered by 
all health planners as it may significantly improve adherence and overall patient well-being.  
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The development of more innovative drug formulations such as other long-acting 
intramuscular ARV injections may also aid in improving ART adherence in this group 
(Margolis et al., 2016). This means that patients will not have to take medication on a daily 
basis thus decreasing the likelihood of treatment fatigue. Long-acting injectable agents may 
be comparable in efficacy to daily oral agents. The LATTE 2 trial found that giving a 
combination of long-acting Cabotegravir (an Integrase Inhibitor) and long-acting Rilpivirine 
(a Non-nucleoside Reverse Transcriptase Inhibitor [NNRTI]) intramuscularly every 4 weeks 
or every eight weeks showed that up to 95% of participants remained virologically 
suppressed at week 32 of follow-up.  
 
2.4.2 Side-effects of Antiretroviral treatment 
When prescribing an ART regimen it is important to consider the side effects as they may 
impact the client’s adherence. Some classes of antiretroviral treatment are associated with 
changes in body shape particularly the Nucleoside Reverse Transcriptase Inhibitor (NRTI), 
Stavudine (Bekker et al., 2008). Until recently Stavudine was still commonly used as a first-
line agent in the treatment of HIV. Some of the typical changes are lipoatrophy - which is the 
loss of subcutaneous fat tissue and commonly involves the face and limbs (Bekker et al., 
2008). It is important to note that these changes cannot be reversed. Since adolescence is a 
period of becoming increasingly more aware of one’s physical appearance, it is sensible to 
avoid the use of Stavudine during this period (Bekker et al., 2008). 
 
2.5 PATIENT-RELATED FACTORS 
Chesney (2000) described patient factors such as drug and alcohol use, gender and age as 
being important in relation to ART adherence. I will discuss how issues such as disclosure of 
HIV status, mental health, substance abuse, gender differences and adolescent high-risk 
behavior impact on ART adherence. 
 
2.5.1 Disclosure of HIV status  
Non-disclosure negatively impacts on retention in care (WHO, 2013). Brown et al. (2000) 
stated that non-disclosure may lead to adolescents hiding their medication and avoiding 
getting refills at the health facility. After conducting focus group discussions with 25 youths 
from an urban primary health care clinic in Chicago, Roa (2007) found that half of the group 
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would skip treatment dosages in an attempt to hide their HIV status. Disclosure can be 
considered two-pronged. In the case of a peri-natally infected adolescent, a responsible parent 
or caregiver should disclose their status to the child in a developmentally appropriate manner. 
Secondly, the infected adolescents may or may not decide to disclose their HIV status to 
others (Nuttal, 2006). Hudelson and Cluver (2015) found that if caregivers had not disclosed 
the infected adolescents’ HIV status to him or her, it may have a negative influence on their 
adherence. The process of disclosure is often delayed due to fear on the part of the caregiver 
or health care worker (Nuttall, 2006). Caregivers may fear indirect disclosure of their own 
HIV status should they disclose to the child. Nuttall (2006:3) further suggests that “disclosure 
of HIV status to children should begin prior to adolescence during a period of relative 
stability in the child’s medical and social environment”. This period could be at a time when 
a caregiver is still primarily responsible for collection and administration of the child’s 
medication. In addition, it could happen when a child is attending a dedicated paediatric 
clinic with support group facilities for both the child and the caregiver (s). 
 
If adolescents disclose their HIV status to a trustworthy person(s), they are more likely to 
receive support in the form of knowledge and resources to help them cope with their HIV 
diagnosis and to access and remain in HIV care (WHO, 2013). However, in a workshop held 
in South Africa to determine the values and practices of young people with HIV, it was found 
that adolescents preferred to keep their status to themselves (WHO, 2013). Merzel et al. 
(2008) however found that disclosure may improve adherence but that this strategy may only 
be effective under certain circumstances. Disclosure may be hindered due to a fear of stigma 
(Nabukeera-Barungi, 2015).  A study done amongst adolescents in Cape Town found that 
young people did not disclose their HIV status to friends as they feared stigma and being 
mistreated by their peers (Cotton et al., 2010). 
 
 
All patients with diseases and disabilities may potentially face stigma but stigma associated 
with HIV is multigenerational in nature and involves many social stereotypes pertaining to 
transmission (Haberer & Mellins, 2009). If an adolescent discloses their HIV status, they may 
thus indirectly be disclosing their parent’s HIV status too and vice versa. Both generations 
may then experience stigma as a result of this disclosure. HIV stigma may involve PLWHA 
and their associates being treated with impartiality and being discriminated against (Parker & 
Aggleton, 2003, as cited in Wei, Xiaoming, Harrison, Zhao & Zhao, 2016). There are many 
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different forms of HIV stigma such as enacted stigma (i.e. overt behaviours) and perceived 
stigma (i.e. awareness of stereotypes) (Herek, Gillis & Cogan, 2009, as cited in Wei et al., 
2016). Pantelic, Shenderovich, Cluver and Boyes (2015) found an association between 
experiencing HIV stigma and negative health outcomes. HIV-stigma is also associated with 
negative emotions amongst children such as sadness and depression (Wei et al., 2016). This 
in turn has a negative impact on ART adherence.  
 
HIV-related stigma and discrimination in the work place and education system is a problem 
faced by many HIV positive adolescents and youth (UNAIDS, 2013). Young people are thus 
at risk of non- adherence to HIV care when faced with discrimination.  
 
 
2.5.2 Mental health  
Mental health problems are more common among long-term survivors of peri-natally 
acquired HIV infection (Mallee & Mellins, 2013). A cohort study of 34 HIV positive 
adolescents in a primarily urban setting in Washington, United States of America, showed 
that 85% of participants had at least one clinical psychiatric disorder or acute symptom that 
required treatment as defined by the diagnostic and statistical manual of mental disorders, and 
at least half had a current or prior diagnosis of depression or another psychiatric illness (Pao, 
Lyon, D’Angelo, Schuman, Tipsin & Mrazek, 2000, as cited in Brown et al., 2000). 
Adolescents with HIV face the same challenges as other adolescents but in addition they have 
to cope with very unique stressors. These may include dealing with stigma, living with an 
incurable illness, exposure to pain and the loss of a parent(s) (Mallee & Mellins, 2013). 
Williams et al. (2006) found that recent stressful events are strongly associated with non-
adherence. Reisner et al. (2009) found an association between non-adherence and mental 
illness especially anxiety and depression. Uthman (2014) found in a meta-analysis that 
patients with depressive symptoms were 42% less likely to achieve optimal adherence to a 
HAART regimen. 
 
An adolescent may be predisposed to mental illness as a result of being HIV positive. 
Efavirenz, from the NNRTI class should thus be avoided in adolescents with a psychiatric 
history (Bekker et al., 2008). Mental illness in HIV positive adolescents can lead to poor 
ART adherence and risk-taking behavior (Laughton, Cornell, Bovin & Van Rie, 2013). This 
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risky behavior can include risky sexual behavior, early sexual debut and substance abuse. 
Mental health practitioners can thus play a very useful role in assessing and maintaining 
adherence (Brown et al., 2000). Brown et al. (2000) and Aylward (2002) also note that 
instead of an adolescent presenting with a clear-cut mental diagnosis some may present with 
very subtle neuropsychological deficits. These features can be determined biologically as a 
direct result of the virus or genetic predisposition or it can be determined by the social 
context.  
 
Malee, Williams, Montepiedra, Nichols, Siroius and Storm (2008) found that HIV positive 
children and young adults have IQ scores in the low average range and 16% of HIV positive 
adolescents compared to 5% in the general population have cognitive impairment. They 
further assert that this cognitive impairment may influence adherence to medication.  
 
Hoare (2016) found that HIV positive youth had poor cognitive inhibition and had poor 
executive function which may impact on daily activities. In addition, they found that HIV 
may affect decision making. All these characteristics are necessary to navigate through 
adolescence, to be less impulsive and to make good decisions about their health such as 
remaining adherent to an ART regimen. The adolescent phase involves physical, cognitive 
and emotional changes (WHO, 2013). WHO argues that because of these changes adolescents 
may have a decreased ability to make important decisions such as decisions about their 
personal lives and health care. This, together with their decreased perception of risk and poor 
cognitive inhibition may impede on their adherence. 
 
The literature on mental health of HIV positive adolescents overwhelmingly points to poor 
mental health amongst this vulnerable group. However, despite HIV positive youth having 
increased vulnerabilities, “…some studies show that many are presenting with behavioural 
health problems that are the same or less than uninfected peers” (Bhana et al., 2016:50). 
Furthermore the authors suggest that a number of studies have found a similar prevalence of 
psychiatric disorders between HIV positive and HIV uninfected youth. They did an enquiry 
into resilience amongst peri-natal HIV positive adolescents in South Africa. The authors 
found that there were numerous factors on an individual, family and community level which 
influence resilience amongst HIV positive youth and help them to cope with a chronic, highly 
stigmatised illness which requires strict adherence to a rigid treatment regimen. Some of 
these factors on an individual level included having self-esteem and self-regulation.  
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2.5.3 Gender differences 
Hudelson and Cluver (2015) in a systematic review of the literature found that there is an 
association between gender and non-adherence to ART amongst adolescents. Gross et al. 
(2013) found that the only independent risk factor for poor adherence was being male with an 
odds ratio of 3.2. It is uncertain from the study exactly how male sex contributes to poor 
adherence and further work in this regard needs to be done. Chesney (2000) also found that 
male gender was negatively associated with adherence to ART. Bakanda et al. (2011) did an 
observational study among various age groups in Uganda and found males on ART had 
higher mortality; this was the largest study of its kind in Africa. Other literature has 
contradictory findings. Williams et al. (2006) found that female gender was associated with 
marginally significant increases in non-adherence. Reisner (2009) in their review of the 
literature also found an inconsistent association between non-adherence and gender. There 
are thus gaps in understanding if gender contributes to non-adherence and if so, how exactly 
it does contribute. 
 
2.5.4 Adolescent risk-taking behavior 
The adolescent phase is often accompanied by the need to experiment and defy authority 
(Adams & Berzonsky, 2006). Adolescents are also particularly likely to succumb to peer 
pressure and as a result experimenting with alcohol and substances in this phase is very 
common. Substance abuse is both an independent risk factor for non-adherence as well as a 
compounding factor for the development of mental illness which in turn leads to non-
adherence (Mellins, 2009). Substance misuse can lead to disinterest in self which may lead to 
non-adherence and substances such as cannabis and amphetamines can lead to frank 
psychiatric problems which may lead to non-adherence. Self-reported Methamphetamine use 
in the Western Cape ranges between 9 and 12% (Plüddemann & Parry, 2012), 66% life time 
alcohol use and 23.6% lifetime cannabis use (MRC, 2011). A study by Chesney (2000) found 
that patient-related factors especially substance and alcohol abuse appeared to be the 
principle factors associated with non-adherence.  
 
In addition to possible mental illness and substance use, adolescents’ sense of immortality 
and invincibility places them at a higher risk of defaulting ART and HIV care. Their sense of 
immortality may make them believe that they do not need ART. Hoare (2016) also asserts 
that adolescent decision-making favours more immediate and tangible reward as opposed to 
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more distant, positive health benefits. Nglazi et al. (2012:25) suggest that adolescence “…is 
often associated with deviations from expected or prescribed behavior”. This, they argue, 
may influence adolescents’ ability to take care of their illness and follow clinic appointments.  
 
2.6 SUMMARY 
Numerous factors have been postulated to be responsible for the decreased adherence to ART 
amongst adolescents. Most of the data however comes from a first world setting and is done 
on either adult or paediatric populations. This data is then extrapolated to adolescent 
populations but this is seldom appropriate. It is however clear that the dynamics of adherence 
amongst the adolescent population is complex. Data on the factors which influence adherence 
to ART amongst adolescents in South Africa is limited and in the Western Cape Province, 
there is no documented research on this subject matter. It is this information that provides the 
impetus for the current study. 
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CHAPTER THREE 
METHODOLOGY 
3.1 AIMS AND OBJECTIVES 
The aim of the study was to explore the factors that influence adherence to ART amongst 
adolescents in a primary health care clinic in a low socio-economic, urban setting in Cape 
Town. The following specific objectives were pursued: 
 
i. To explore socio-economic factors that may influence adherence to ART among these 
adolescents 
ii. To explore the health-systems factors that influence adherence to ARTs 
iii. To explore the therapy-related barriers to adherence to ARTs 
iv. To explore patient-related factors that influence adherence to ART  
 
3.2 STUDY DESIGN 
An exploratory qualitative design was employed as it enabled the researcher to gain better 
insight into the unique individual, cultural and contextual challenges related to ART 
adherence in this research setting (Baum, 1995). This design was chosen because ART 
adherence is considered a very complex phenomenon and requires an in-depth understanding 
of the socio-cultural as well as the biological environment in which it occurs - it cannot 
exclusively be explained by straight forward patterns of causality. Qualitative research is 
interested in understanding a phenomenon from the perspective of the participants. In this 
case the researcher was concerned with understanding the meaning which HIV positive 
participants on HAART attach to the factors which they believe may influence adherence.  In 
addition, the researcher sought to gain an understanding of what key-informants such as 
health care workers believe may influence adherence. 
By collecting qualitative data, the researcher was able to provide thick and rich descriptions 
of the study topic (Jack, 2006). This form of data collection allowed participants to tell their 
own stories which in turn assisted the researcher to understand the meaning which 
participants assign to their experiences with ART.   
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3.3 STUDY SETTING 
This qualitative enquiry took place at a primary health care clinic, which was located in an 
urban residential area in the greater Cape Town area. The township is home to a 
predominantly black community. During discussions with the research assistant I also learnt a 
lot about the community. She lives in the area where most of the participants live and gave 
me useful insights regarding the general household set-up in the area as well as common 
family dynamics. She also orientated me to the community dynamics. During the previous 
political regime (Apartheid) this community was largely marginalized and exploited. The 
area covers 13.46 square kilometers and has a total population of 64 269 with more or less 
equal numbers of males and females. Of this number 96.3% are African, 2.7 % are Coloured 
and 0.2% are White (Statistics South Africa, 2012). It is part of the Cape Town metro which 
carries the heaviest burden of HIV disease in the Western Cape (5.2%).  
 
The health facility where the research took place is one of two health facilities in the area in 
which it is located. Locally it is referred to as the TB clinic or the Baby clinic to distinguish it 
from the other health facility in the area. The clinic provides immunization services, care for 
sick babies, TB treatment for drug susceptible and drug resistant TB and HIV care for adults 
and children (wellness care and ART). It also provides ante-natal care and family planning 
services. HCT is also performed at this clinic. The clinic is open Monday to Friday from 
07:30-16:30. It is closed on the weekends and public holidays. The clinic has a pharmacist, 
two resident doctors, nurses, admin staff and a psychologist who comes to the clinic once a 
week. In addition, the facility also receives assistance from many non-governmental 
organisations. 
 
It is situated adjacent to a high school and opposite a primary school. A number of the youth 
who access this facility come from these two surrounding schools and would utilize the clinic 
facility before or after school. The number of adolescents who access the clinic for ART and 
HIV care is not known as adolescent data is categorized as either paediatric or adult data. 
 
3.4 STUDY POPULATION AND SAMPLING 
The study population comprised of HIV positive individuals between 10 and 19 years of age 
(adolescents as defined by WHO) who are enrolled for ART at the selected primary health 
care clinic in 2015/2016.  
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Twenty six participants were recruited into the study. Twenty signed informed consent forms 
were returned prior to commencing data collection. The final sample consisted of 17 
participants. Two participants were very late for the Focus Group Discussion (FGD) and were 
thus excluded. Potential participants’ clinic files were screened beforehand and then 
approached for their participation. Details such as demographics, ART initiation date, ART 
regime, adherence and latest viral load were recorded. This was essential to ensure a sample 
with maximum variation.  
 
This particular sample size was selected as it was thought that it would not lead to under or 
over representation of certain groups and opinions. The researcher also thought it may be 
unlikely to recruit a larger number of adolescents as they may be reluctant to engage in 
honest conversation with someone they perceive to be in a position of authority. This is due 
to the researcher previously having been a medical doctor at this particular facility and the 
power dynamics that exist between the patient and practitioner may impede honest discussion 
especially when participants are much younger. All participants were attendees of the facility 
where the research took place.  
 
In the proposal submission I had said the study population would be between 10 and 19 years 
old. However, two of the participants matriculated last year (20 and 22 years old respectively) 
and the other 20 year old was still in Gr.12. There was also a young lady who is pursuing 
tertiary studies at a local college. I thought it appropriate to include them in the sample as 
they were likely to experience similar issues to that experienced by other adolescents. I 
employed purposive sampling with the help of a research assistant. Participants were 
recruited into the study based on the following characteristics: 
 
 HIV positive on life-long ART for at least six months 
 Between 10 and 22 years old 
 Participants were resident in the area where the research took place as well as 
neighbouring areas. These areas are in close proximity to one another with similar 
socio-economic status 
 
 
 
 
 
 
 
21 
 
A final sample was generated to ensure maximum variation: 
 50% were younger than 15 years old and 50% older than 15 years old. 
 There was a mixture between adherent and non-adherent participants. This was 
determined by perusing participants’ clinic notes prior to the FGDs. In the clinic notes 
participants’ adherence and viral loads were documented. 
 Similar representation of males and females. 
 
3.5 SUMMARY DESCRIPTION OF SAMPLE 
Study participants were adolescents and young people who accessed ARVs at the particular 
health facility at the time data collection was taking place. Participants were all on ART for at 
least one year when data collection commenced. There were male and female participants and 
there was a mixture between adherent and non-adherent participant. Participants’ clinic notes 
were screened prior to data collection. 
 
3.6 PROCESS OF NEGOTIATING ACCESS TO THE FACILITY 
Previously the researcher was employed at the facility in her capacity as ART physician. She 
occupied this position from 2011-2014. During the latter part of 2014 the researcher 
developed a keen interest in the study topic and informally engaged with staff to determine 
what they thought the feasibility of such a project would be.  
During 2015 an informal meeting was held with the facility manager to inform her of the 
proposed study. At the time I was still waiting to receive ethical approval from the University 
of the Western Cape. The research assistant was also approached at the time. A subsequent 
meeting followed with the facility manager on 21 January 2016 where I was advised on the 
process of applying for ethical approval from the City of Cape Town. In principal the facility 
manager accepted my request to conduct the project at this primary health care facility 
pending approval from the City of Cape Town and the sub-district manager. 
An online application for access to the facility was made to the City of Cape Town on the 
23
rd
 of January 2016. On the 26
th
 of February 2016 approval was received from the 
subdistrict manager dated 08 February 2016 (Appendix J).  
The resident ART doctors and nursing staff were approached and a meeting was set up with 
them. During this meeting I discussed my proposed plans for the project and aimed to obtain 
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their buy-in. They were willing to assist wherever necessary. A separate informal meeting 
was also held with the visiting psychologist. During this meeting I informed her of my plans 
and requested her assistance with referrals if I discovered during the interviews that a 
participant may need to be seen by a psychologist. She agreed to this. Two participants were 
referred to her. 
 
3.7 RESEARCH ASSISTANT 
The research assistant is an employee at the facility where the project took place. She was 
approached last year (2015) to enquire if she would be interested in participating in the 
position as research assistant. She is currently employed as a HIV and TB clerk at the facility. 
She is fluent in English and Xhosa. I approached her as she knows the clinic system very 
well, she enjoys working with youth and she has previously worked on a research project. 
Our first official meeting took place on the 18
th
 of February 2016. She was briefed on the 
purpose of the study as well as the format.  
Numerous meetings and training sessions took place between the researcher and the research 
assistant. The assistant was also provided with tools such as stationery and airtime to contact 
potential participants as well as copies of the participant information sheet and informed 
consent forms so that she may be familiar with the content. The research assistant was briefed 
on the general purpose of the project, its aims and objectives. She was trained on the ethics of 
qualitative research and the utmost importance of maintaining participants’ anonymity and 
confidentiality. We also discussed what her expectations were and misinterpretations and 
misunderstandings about the purpose of the project were corrected. Furthermore the process 
of sampling was discussed and how she would assist me with this. In addition I conducted 
training with her regarding focus group discussions and one-on-one interviews as she would 
also be assisting me with translation during these interviews should the need arise. 
The research assistant was incredibly optimistic and helpful. I personally debriefed the 
assistant after each data collection event which she was a part of. She was also aware that she 
could call me at any time if she required further discussion regarding certain elements which 
she may have found difficult to deal with such as hearing accounts of trauma experienced by 
participants. When all data collection was complete, both the assistant and researcher were 
jointly debriefed by the researcher’s supervisor. This final debriefing was done one day after 
the last data collection event. 
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3.8 DATA COLLECTION METHODS AND PROCEDURE 
The researcher conducted all the data collection events herself and employed the assistance of 
a Xhosa-speaking interpreter only where absolutely necessary. The main source of data was 
semi-structured in-depth interviews and FGDs which were audiotaped with a digital recorder 
and transcribed verbatim. It was also translated to English where necessary. The data 
collection started with two individual key-informant interviews which were conducted with 
two nursing sisters who provide HIV and ART services at the facility. These interviews were 
conducted in English and were very informative. The key informant interviews generally 
orientated me to the subject.  
Four focus group discussions were held in a language the participants preferred i.e. English or 
isiXhosa and at a time that suited them. The groups were divided according to age and gender 
as follows: 
i. Girls 10-14 years old – 3 participants 
ii. Girls 15 years and older – 7 participants 
iii. Boys 10-14 years old – 4 participants 
iv. Boys 15 years and older – 3 participants 
 
The focus group discussions were followed by eight individual in-depth interviews. Two 
participants were selected from each FGD. Those who appeared to have further valuable 
insights to render were approached after the FGD to be interviewed individually. These 
individual in-depth interviews were also conducted in the language of the participant’s choice 
i.e. English or isiXhosa. They were audio taped and transcribed verbatim. All data collection 
took place at the health facility. Data collection was completed in five weeks and the original 
estimate was four weeks. The assistance of a transcriber and translator were employed. The 
research assistant was also the translator. The researcher also took notes during all interviews 
and paid careful attention to verbal and non-verbal cues.  
The interviews and FGDs were semi-structured making use of open-ended questions and 
prompts. An interview guide was compiled for this purpose in order to ensure standardization 
(Appendix H, I & J).  
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3.9 DATA ANALYSIS 
Data analysis is used to generate meaning and understanding from the large volumes of data 
generated in qualitative research whilst trying to maintain the integrity and trustworthiness of 
the data. To analyze the data I have made use of content analysis. Content analysis is 
generally a more detailed form of data analysis and is widely used to analyze qualitative data. 
Hseish and Shannon (2005) propose three approaches to qualitative content analysis namely 
conventional, directed and summative content analysis.  I found conventional analysis better 
suited to this qualitative enquiry. In this type of analysis codes are derived from text data 
directly. Conventional content analysis is generally used where the study design is descriptive 
and to allow new categories and ideas to emerge from the data as opposed to imposing 
preconceived notions on the data. It involves grouping the data initially into codes; and then 
placing them into categories and finally forming themes.  
 
Analyzing the data started with reading and re-reading the transcripts several times. This was 
done concurrently with reading the field notes, personal reflections and reading entries from 
my research diary. The field notes proved invaluable as the researcher was able to reflect on 
non-verbal cues and subtle nuances of the participants which she made a note of during the 
interviews. Transcripts of the key informant interviews were also used to orientate the 
researcher to the data. Transcripts were analyzed one at a time starting with the focus group 
discussions.  
 
Transcripts were initially read twice. On reading it a third time the researcher made pencil 
notes in the margin of all the main issues that relate to disengagement with care which came 
out from the text. The researcher was as inclusive as possible and also considered the things 
which were not being said such suggestive statements and links between statements in 
different parts of the interview. Then, the list of all codes was transferred onto a separate 
page. In the next step the researcher re-wrote the list of codes but this time highlighting codes 
which were duplicated or emphasized by the participants.  Similar codes were then grouped 
together and in the last step themes were developed. 
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3.10 RIGOUR 
Rigour is applied to ensure credibility and trustworthiness of the data. Rigour was applied at 
every point of the research enquiry. I employed the following strategies to ensure the data is 
rigorous. 
 
Reflexivity means the researcher must be consciously aware of herself - her possible biases, 
preconceived ideas about the topic, etc. I constantly engaged with myself by keeping a 
journal documenting how I was thinking and feeling at every stage of the process. After every 
data collection event I wrote a reflection on the process and how I was feeling at the time and 
submitted this to my supervisor within 24 hours of the data collection event. As I am trained 
in a more reductionist philosophy, I had to constantly remind myself to be receptive to the 
idea that new knowledge will be gained from the participants and not approach the subject 
matter with a hypotheses already in mind. This was further enhanced by the manner in which 
the questions were asked i.e. open-ended questions as part of semi-structured interviews. 
Researcher reflexivity took place at every point during the research. 
 
Triangulation is a process whereby the “…researcher searches for convergence among 
multiple and different sources of information to form themes and categories in a study” 
(Cresswell & Miller, 2000:126). During the research project I searched for common themes 
in the different elements of the process namely the literature review, individual in-depth 
interviews and focus group discussions and during analysis of the data.  
 
In addition I provided thick, rich descriptions of the study participants, study setting and the 
themes of the study. This entailed giving dense and detailed accounts of the participants, the 
study setting and the themes of the qualitative study (Cresswell & Miller, 2000). It also 
involved providing very fine and detailed information. According to Cresswell and Miller 
(2000) a thick description makes the study tangible to the reader. Thus, because thick 
descriptions create the feeling that the reader is able to experience the events, it adds 
credibility to the study. 
 
3.11 ETHICS CONSIDERATIONS 
Permission to conduct the research was obtained from the Biomedical Research Ethics 
Committee of the University of the Western Cape (Appendix I). Permission was also sought 
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from the Department of Health. Participation in the research was completely voluntary and 
the identities of the participants were protected. I explained to participants that I would like 
them to be part of the research until the entire process has been completed but they may 
withdraw consent at any point if they are unwilling to continue. I am of the opinion that the 
study was of benefit to the participants and other adolescents who may need ART as it will 
give us insight into what we can do to enhance adherence to ART and ultimately to have 
better health outcomes. The participants may have benefited as they may have found that the 
FGD was a support mechanism when they realized that others face similar problems to what 
they are facing. The intention of the researcher was not to bring any harm to participants in 
any form but the researcher realized that inadvertent emotional/psychological harm may 
come to participants when for example sensitive or traumatic topics come up. The researcher 
was acutely aware of this and when it appeared that a participant was distressed then 
arrangements were made for appropriate referral if the researcher was not able to herself 
remedy the situation. I also made the resident psychologist at the facility aware of my 
intended research. Everyone who met the criteria had equal access to participate in the 
research. No-one was given preference. In this way the principle of justice was adhered to.  
 
The participants were between 10 and 22 years old. As anticipated, a large number of 
participants were under 18 years old and thus parental consent had to be obtained. For 
participants between the ages of 10 and 18, the participant had to provide assent and the 
parent/caregiver had to grant consent. For those older than 18, only participant consent was 
required. I designed a consent form in Afrikaans, English and Xhosa as well as an assent 
form in these languages. The participant information sheet was also available in Afrikaans, 
English and Xhosa.  There was a participant information sheet for participants and one 
designed for parents/guardians. In addition, participants who were part of the focus group 
discussion had to sign a focus group confidentiality binding form (Appendix E) in which they 
agreed to uphold the confidentiality of the group discussions by not disclosing the identity of 
other participants as well as their contributions. The researcher protected participants’ 
confidentiality at all cost but it is up to all those in FGD to uphold confidentiality of other 
participants in the group. The risk of a participant of a FGD breaking confidentiality could 
not be completely excluded. 
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CHAPTER FOUR 
RESULTS 
4.1. INTRODUCTION 
This chapter outlines the results of the study. The first section presents a description of the 
study participants, the second the barriers to ART adherence, and the last section those 
factors that facilitated ART adherence among HIV positive adolescents on ART who 
participated in this research study.  
 
4.2. DESCRIPTION OF STUDY PARTICIPANTS 
Study participants were adolescents between 10 and 22 years old who accessed ART at a 
primary health care clinic in a low socio-economic urban area on the outskirts of Cape Town 
at the time of the study. Participants older than 19 years were included as they were either 
current or recent school-going adolescents and considered to be experiencing similar issues to 
adolescents who met WHO definition of 10-19 years.  
Seventeen adolescents were recruited into the study of which ten were female and seven male 
(Table 4.1). Eight participants were between the ages of 10 and 15 years (early adolescence) 
and nine were older than 15 years (late adolescence).  
Most respondents (n=13) were on first line ART which included two Nucleoside Reverse 
Transcriptase Inhibitors (NRTIs) and one NNRTI; four were on second line ART which 
consisted of two NRTIs and one Protease Inhibitor (PI).  
More than half of the sample of participants (n=10) had optimal adherence which is defined 
as greater than 95% adherence to a daily drug regimen (Table 4.1) (Bekker et al., 2008), 
while 41.1% (n=7) had poor adherence as recorded in their clinical records.  
Five (29.4%) participants’ clinical records lacked regular viral load result documentation. Of 
those who had a viral load result documented in their clinical records only six were recorded 
as being virologically suppressed in the preceding year.  
Furthermore, the exact commencement date on HAART was not documented for eight 
participants as only the year the patient started ARVs was recorded. However, it was 
definitely more than a year as per study inclusion criteria. 
 
 
 
 
28 
 
Table 4.1. Demographic and clinical characteristics of participants 
Participant Age Gender Schooling Adherence Last VL ART initiated ARV regimen 
1 22 Female Matriculated 
2015 
Good Lower than 
detectable 
Limit (LDL) 
(2014) 
24/11/2006 2
nd
 line 
2 17 Female Gr.7 Poor 105 (2015) 2013 2
nd
 line 
3 20 Female Matriculated 
2015 
Good LDL (2015) 2015 1
st 
line 
4 20 Female  Gr.12 Good  2015 1
st
 line 
5 15 Female Gr.9 Poor 22 (2015) 2015 1
st 
line 
6 22 Female Tertiary 
College 
Poor 777 (2015) January 2014 1
st
 line 
7 17 Female Unknown Good  25/04/2015 1
st
 line 
8 14 Male Gr.7 Poor 1454 (2014) 17/07/2011 1
st
 line 
9 14 Male Gr.8 Good   1
st
 line 
10 10 Male Gr.5 Good LDL (2015) 17/04/2014 1
st 
line 
11 13 Male Gr.7 Improved LDL (2016) 26/03/2004 2
nd
 line 
12 18 Male Gr.12 Good LDL (2014) 30/05/2006 1
st 
line 
13 16 Male Gr.10 Good 54 (2015) 16/01/2015 1
st
 line 
14 18 Male Gr.10 Poor   2
nd 
line 
15 10 Female Gr.3  Good LDL (2015) 2006 1
st
 line 
16 13 Female Gr.6 Good  +/- 2012  
17 13 Female Gr.7 Poor 108(2014) 2007 1
st
 line 
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4.3. BARRIERS TO ADHERENCE 
The reported barriers to ART adherence (Table 4.2) were organised according to the 
following main themes:  
 School factors;   
 Socio-economic factors; 
 Health services factors; 
 Therapy related factors; and 
 Patient factors 
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Table 4.2. Barriers to adherence  
THEME SUB-THEME DESCRIPTION OF CODE 
SCHOOL FACTORS Conflict between school and 
clinic 
Afternoon classes 
Communication about absence from 
classes 
Strained relationships with 
teachers 
Negative teacher attitudes 
Fear of unintended disclosure by teachers 
SOCIO-ECONOMIC 
FACTORS 
Lack of financial support Pay someone to collect medication 
Access private health care  
Transport expenses 
Buy ARVs  
Household dynamics Ill treatment by caregivers  
Only HIV positive sibling 
Feels like an outcast amongst family 
HEALTH SERVICES 
FACTORS 
Service delivery Long waiting times 
Nursing staff shortages 
Missing files 
Long travelling distance to clinic 
Unintended disclosure 
Quality of care Negative health care worker attitudes 
Unsupportive health care system 
Discrimination against treatment defaulters 
Verbal abuse 
Inappropriate management of health 
complaints 
Disrespect shown to parents 
THERAPY-
RELATED 
FACTORS 
Medication Factors Side effects 
Pill burden  
Medication unpalatable 
Treatment Routine Treatment fatigue 
Interferes with leisure activities 
Rigid treatment schedule 
Forgetfulness 
PATIENT FACTORS Disclosure Dynamics of disclosure 
Fear of stigma and discrimination 
Denial  
Forbidden to disclose 
Lack of knowledge about diagnosis 
Perceived stigma Fear of being stereotyped 
Routine creates suspicion 
Adolescent behaviour Feeling invincible 
Unstructured lives 
Alcohol use 
Rebellion 
Mental health Shame at mode of HIV transmission 
Anger at mother for peri-natal 
transmission of HIV 
Depression 
Loneliness 
Disease factors Feeling well 
No physical benefit of treatment 
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4.3.1 School factors 
The factors in the participants’ school environment that impacted negatively on their ART 
adherence were Conflict between school and clinic times and Strained relationships between 
learners and teachers. 
 
Conflict between school and clinic 
Participants identified two areas of conflict between the school and the clinic which impacted 
on their ART routine and clinic visits, namely The need to attend afternoon classes; and The 
need to communicate with teachers when they will be absent from class.  
 
Afternoon classes 
Participants were required to attend afternoon classes on most days after school. These 
classes were held at the same time that they would usually go to the clinic to collect their 
medication. Thus they had to make a choice of, either attending additional classes at school 
or going for scheduled clinic visits and/or collect medication. Clinic visits usually take place 
on a monthly basis. Patients are informed of the date for collection of the next months’ 
supply of medication. This means that patients are required to return to the clinic on that 
scheduled follow-up date which is normally on the day the medication finishes or the day 
before. 
In school we have different periods…, and here [at the clinic] you are told to come 
after school because they [the clinic staff] can’t help you. So I personally prefer to 
come after school, but that means I have to miss the afternoon classes. - 17 year old 
girl 
  It would be nice for us to come at our own time, so that we do not have to miss our 
school work. That way we can be able to balance our life. Your school work doesn’t 
suffer because of the clinic appointments, and vice versa. - 18 year old boy 
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Communication about absence from classes 
The participants reported that they had to obtain permission from their class and/or subject 
teachers to go to the clinic. Participants found this particularly difficult as they preferred not 
to reveal the exact reason for clinic visits to all their teachers and found this type of 
communication quite challenging. They feared that disclosing to the teacher that they have 
HIV and must go collect their ART is risky because it may lead to unintended disclosure. 
They feared that teachers may unintentionally reveal their status to others in the class. They 
also felt that it may be difficult for teachers to understand their health dilemma which 
involves having a chronic illness requiring regular clinic visits and which is highly 
stigmatised. 
During the day it is difficult to miss the classes because we have different periods with 
different teachers, for example if you tell your class teacher s/he might not tell others 
that you have this problem because other teachers are not understanding. -  20 year 
old girl 
 
Strained relationships with teachers 
Some participants described the relationship with their teachers as strained. This posed a 
barrier to adhering to clinic appointments. The strained relationships with teachers were the 
result of Negative teacher attitudes and Fear of unintended disclosure of their HIV status by 
teachers. 
 
Negative teacher attitudes 
Some respondents described their teachers as having negative attitudes. They perceived their 
teachers to have dismissive attitudes towards them. Many respondents opted for selective 
disclosure and did not necessarily want to tell their teachers of the exact reason for their clinic 
visit because they feared teachers’ response should they tell them. 
Another problem when you ask a permission to go to the clinic, the teachers are so 
curious they want you to tell them the reason for your visit…And when you refuse to 
tell them they will assume that you are going for family planning and they will be 
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angry. Their attitude makes it difficult for you to sit him/her down and explain your 
problem. - 20 year old girl 
 
Fear of unintended disclosure by teachers 
Participants were concerned that teachers may inadvertently reveal their status to others, such 
as fellow learners when they are angry. Previous experience with some of their teachers made 
them weary of sharing sensitive information such as their HIV status with them.   
Okay my life orientation teacher is not a friendly person. She likes to shout, beat and 
[is] always angry. When she is angry, she says a lot of things out of anger; imagine 
now if you tell her about your status, and when she is angry she burst out in front of 
everyone. The best way is to keep this to myself. - 16 year old boy 
 
4.3.2. Socio-economic factors 
This section describes how social factors impact on adherence. Social factors can be defined 
as influences such as economic and living conditions which shape the conditions of daily life. 
Participants reported that a Lack of financial support and Household dynamics impact 
negatively on ARV adherence. 
 
Lack of financial support 
Participants identified four ways in which having financial support (or means) could facilitate 
adherence to treatment, namely Paying someone to collect their ARVs, Accessing private 
health care, covering Transport expenses to the health facility and Buying antiretroviral 
medication should they run out. 
 
Pay someone to collect medication 
Participants suggested that having financial support or means could enable them to pay 
someone to collect their medication on their behalf.  In this way they would not be seen 
waiting to receive HIV care and thus unintended disclosure would be avoided. They 
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expressed that this would assist them with adherence to clinic appointments and consequent 
ART adherence as they would then collect their medication on a regular basis and thus not 
run out of treatment.  
Actually I was going to hire someone so that someone can help me to go and fetch my 
treatment for me and bring it back to me and I can pay back yah that is what I was 
going to do. Some of us are afraid of people, you can take your medicine and drink 
but when you come back they gonna stare. You get scared of the people. You are 
scared of what people will say about your pills, they can be so judgemental. Hiring 
someone would make things much easier. -  18 year old boy 
 
Access private health care  
Some participants mentioned that they would like to have the option of accessing private 
health care facilities in areas other than where they currently reside. In order to do this they 
would need financial assistance as private health care in South Africa is not free. They felt 
that this would aid in avoiding unintended disclosure and as such help with adherence. 
P2: I will tell that person at home that I should go to private clinic or hospital  
F: Okay so you would use the money for private hospital, why would you do that? 
P2: Because I do not want to be seen  
F: And you think when you come here to this clinic somebody can see you? (P2 
interjects: Yes) So would you go to a private hospital in this area or other 
area? 
P2: I would go [to] other area. - 14 year old boy 
 
Transport expenses 
A barrier highlighted to accessing clinic care was lack of money for transport to the health 
facility. Participants expressed that financial support would aid with transport expenses to the 
clinic which in turn would help them to adhere to clinic appointments. 
…I can take a transport to come to the clinic. - 14 year old boy 
  Oh… maybe I can use it [financial support] for a taxi fare to collect my medication. - 
18 year old boy 
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Buy antiretroviral medication 
Participants noted that financial support would assist them with adherence by purchasing 
ART privately should they run out of medication. This would be particularly useful at the 
times when the clinic is not accessible for example in the evenings, over the weekends and on 
public holidays. 
If my pills were not enough I would buy more so that they can sustain me till my next 
date. At times the clinic can be very busy full of people, so if I had money, I would not 
wait in the queues. - 13 year old girl 
 
Household dynamics 
Negative household dynamics were reported to have adverse impacts on adherence for 
participants in the current study. Some of the respondents were orphaned and had strained 
relationships with their caregivers. The household dynamics identified which presented 
barriers to adherence were Ill-treatment by caregivers, Being the only HIV positive sibling 
and Feeling like an outcast amongst family members. 
 
Ill treatment by caregivers 
Some participants highlighted that they were being ill-treated at home by their caregivers. 
Those who were fostered reported that caregivers would insult them with harsh words and 
blame them for their own infection. This impacted negatively on their relationship with 
caregivers which resulted in participants feeling lonely and discontinuing their medication as 
they too wanted to be deceased like their parents. This phenomenon appeared to be 
particularly common amongst the participants who were orphaned and were cared for by 
relatives or foster parents. 
  Yoh, when I am feeling bad, I stop taking my pills. For example, when I have 
quarrelled with my mother, - sometimes she says things that are not so nice. Like 
saying she never infected me. My mother is not my biological mother mos. My 
biological parents are dead. So when she talks like that I feel lonely and I feel bad, I 
stop taking the pills because I also want to die. - 18 year old boy  
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Being the only HIV positive sibling 
Some participants found it hard to come to terms with their HIV status when they are the only 
sibling who is HIV positive and all other siblings were HIV negative. This led to denial 
which in turn influenced adherence. 
My mother told me that she is also positive. But my question is:  we are three but I am 
the only one who got infected. How did that happen? I am still asking myself. - 16 
year old boy    
 
Feels like an outcast amongst family 
One participant expressed that his HIV status made him feel like he did not belong to his 
family. He felt that if he were HIV negative he would feel a greater sense of belonging 
amongst them. He expressed that he wished to stop taking his ART in order to be more like 
his family. 
 I would not feel different from them [if I was HIV negative], now I feel like an outcast, 
I am the only person with this thing [HIV] and I do not belong here, I feel like staying 
away from them... I wish I could stop taking medication [ART] and be like them. - 18 
year old boy 
 
4.3.3 Health services factors 
The factors related to the health care services which impacted negatively on participants’ 
ART adherence were: Service delivery and the Quality of care received.  
 
Service delivery 
Participants identified service delivery issues such as Long waiting times, Nursing staff 
shortages, Missing/misplaced files, Long travelling distances to the clinic and Unintended 
disclosure as barriers to ART adherence. 
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Long waiting times 
Long waiting times were identified as a significant deterrent to adhering to clinic 
appointments in all focus group discussions and all one-on-one interviews. Participants 
mentioned that regardless of what time of the day they presented at the clinic they would 
inevitably wait a long time before they are assisted. Waiting times were experienced as very 
stressful as some participants would come to the clinic very early hoping to be assisted and 
still go to school. However, this was often not the case and they would leave the clinic very 
late. As a result, participants would miss clinic appointments in order to avoid being absent 
from class and indirectly this would negatively impact on treatment adherence. 
…sometimes if you come here at half past 8 and the doctor doesn’t attend you… 
doctors can make you wait for a very long time before they can attend you. You can 
come here at 8am and they only start to attend you at 9. Mind you, you will go home 
at 4 that is why I get bored… - 13 year old girl 
  You come here with the hope that you will spend few hours and go home; 
unfortunately you come in the morning and leave in the afternoon when the cleaning 
staff already started cleaning. - 18 year old boy 
 
Nursing staff shortages 
During the interviews participants mentioned that when accessing the clinic at certain times 
of the day, such as after school, they would experience a shortage of nursing staff to assist 
them. This would make clinic appointment adherence as well as treatment adherence difficult 
since nursing staff are required to review patients clinically and prescribe medication. This 
would mean that patients had to access the clinic on a different day which in turn leads to 
school absenteeism and running out of medication. 
If I go to school in the morning and come here in the afternoon, I find nurses gone. -   
15 year old girl 
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Missing/Misplaced files 
Participants mentioned that at times reception staff would not be able to find their clinic file. 
Without adequate clinical records it is very difficult to assist patients especially those on 
chronic medication such as ART. Patients would thus be requested to come to the clinic on a 
different day to allow reception staff to find their clinic folder. This discouraged participants 
from following up for clinic visits and thus led to them missing clinic appointments and 
running out of treatment. 
I do go home without help, they keep losing my folder and sending me home and ask 
me to come back tomorrow. When I come again, they will say it is you again, and they 
are not keen to help me. Mind you I ran out of medication. - 15 year old girl 
 
Long travelling distance to clinic  
Participants mentioned that they had to commute a very long distance to access the health 
facility. This was so regardless of whether they were coming from home or from school.  
However, they also acknowledged the necessity of going for regular clinic follow ups 
regardless of the exorbitant distances they had to travel to the health facility. The long 
travelling distances may however prove a barrier to some. 
Because I am walking a long walk from school and come back and it is … It is a must 
for me to come here irrespective of the long distance I travel from school. - 14 year 
old boy 
 
Unintended Disclosure 
This particular health facility is divided into four sections- a pharmacy, a sick baby/ 
immunisation section, a Tuberculosis department and a section for patients who are coming 
for HIV care and follow-up. Therefore, depending on what service patients are coming to the 
clinic for they would be guided to go wait in that particular section. Where you wait in the 
clinic was thus an indication of what type of care you are seeking. Participants were thus 
concerned that the section they were waiting in may lead to unintended disclosure of their 
HIV status. 
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One time I came to fetch my medication and I saw my neighbour, now she knows [I 
am HIV positive] because it’s obvious that people who wait this side are HIV 
positive… - 16 year old boy 
 
Quality of care 
Poor quality of care negatively impacted on treatment and appointment adherence. Some 
quality of care matters highlighted were Negative health care worker attitudes, 
Discrimination against treatment defaulters, Verbal abuse experienced from HCWs, 
Inappropriate management of health complaints and Caregivers being treated with 
disregard.  
 
Negative health care worker attitudes  
Participants reported that in some cases patient-staff relations impacted negatively on 
adherence. Some participants experienced unpleasant interactions with health care workers 
which had an adverse impact on their adherence. They felt that health care workers were rude 
towards them and thought this could be due to health care workers experiencing a lot of 
stress. 
Some of the nurse[s] they have…what do I say… they are cheeky yah like when they 
have stress, they take out their stresses to innocent people. - 13 year old boy 
 
Unsupportive health care system 
Key informants felt that the health care services rendered at this facility did not focus on the 
specific needs of adolescents and that systems were needed in order to cater for their unique 
needs. 
I don’t think we have systems in place yet because there is nothing that focuses on 
them (adolescents). They are just in another group of adults taking ARVs so there is 
nothing focusing specifically on assisting them so I would say we do not have a 
system that really supports them maybe if we could establish something that really 
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focus on them because [they] are just dumped among the adults because they are just 
part of the whole group who is taking the ARVs. - K.I.  
 
Discrimination against treatment defaulters 
Participants witnessed how patients who had defaulted their treatment and clinic follow-up 
visits were discriminated against when they returned to the clinic to re-start their medication. 
They described that those who had good adherence would receive preferential treatment. One 
participant, who was defaulting at the time of data collection, cited that the reason he was not 
going back to the clinic was because he too will be discriminated against by being made to 
wait until those with good compliance have been assisted and will experience verbal abuse 
should he return to re-start his medication.  
F: What is the reason you feel that you can’t come to the clinic to get a card and 
re- start your treatment?  
P: Is that I am scared because it’s been a while since I came to the clinic.  
F: And what are you scared of?  
P: Like the doctor is going to shout at me  
F: Anything else?  
P: The doctor will shout at me, and I will have to wait at the clinic since they will 
start with the non-defaulters. That makes me angry. - 18 year old boy  
 
Verbal abuse 
Some respondents reported that they were shouted at by HCWs. They felt that this kind of 
verbal abuse discouraged them from following-up for clinic visits especially when they had a 
valid reason which barred them from coming to the clinic. This is how a 14 year old 
participant responded when asked what would encourage him to be more compliant with his 
ARTs and clinic appointments. 
By other people when they support me and the nurse doesn’t shout at me when I skip 
a day. When they told me to come and then I have a something or a problem then I 
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don’t come. When I come back then they shout at me. It makes me feel not to come 
back. - 14 year old boy 
 
Inappropriate management of health complaints 
Some participants were unhappy with HCW attitudes/responses to their complaints. They felt 
that when they had a genuine health complaint that this was not taken seriously by HCWs and 
that they did not receive the appropriate treatment for their health concerns. 
There are some of the staff members that shout at you or put you down when you tell 
them you have something [a medical complaint]. They put you down and say no, that 
will go away in no time but that time you are the one feeling the pain. It is sore. - 13 
year old girl 
 
Caregivers being treated with disregard 
Some participants experienced HCWs as being disrespectful towards their parents. This 
occurred when the accompanying parent was unable to give a good account of their HIV 
positive child’s wellbeing. Participants experienced witnessing their parents being 
disrespected as very stressful, especially when the parent accompanying them to the clinic is 
not the primary caregiver. These negative attitudes by HCWs contributed to poor adherence. 
My mom doesn’t know my problem, when the doctors ask what’s wrong with the 
child; she will point them to me. They do not like that, they say to my mom, why do 
you want us to ask the child when you are here. She tells them that I do not stay with 
her, I stay with my sister. The doctors sometimes become mean to my mom, sometimes 
they just let us be. - 13 year old girl 
 
4.3.4 Therapy-related factors 
The therapy-related factors that impacted negatively on ART adherence were Medication 
factors and the Treatment routine. 
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Medication factors 
This section will focus on the impact Side effects, Pill burden and Palatability of medication 
has on treatment adherence. 
 
Side-effects 
Many participants reported that side-effects of the ART were a barrier to treatment 
adherence. Nausea, vomiting and dizziness were commonly reported side-effects. 
Anticipating these side-effects discouraged participants from taking their ART. 
I don’t feel good because the pills that I am drinking they make me feel like I am going 
to vomit and every day when I think that I feel like I will not drink the pills. - 14 year 
old boy                                       
 
Pill burden 
Participants reported poor compliance due to the high pill burden. This phenomenon 
manifested itself particularly amongst those on a second line ART regimen who said they 
would be more compliant should they be placed on the once daily Fixed-Dose Combination 
(FDC). However, it appears they did not realise that if you are on second line ART (which 
includes a PI that has to be dozed twice daily) that you could not be placed on the once daily 
FDC. The following was mentioned by a participant who was defaulting 2
nd
 line ART at the 
time the FGD took place. 
Also I would love them to change my stream and put me on the one tablet regime, if I 
can have only one tablet I can comply with my medication. - 18 year old boy 
 
Medication unpalatable 
Some participants who were on a second line ART regimen which included Alluvia, a PI, 
mentioned that the tablets were big and unpalatable and that this discouraged them from 
taking their medication. 
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…its tiring and boring to take this medication for all the time it is not nice... and its 
[the tablets] big… - 22 year old girl 
 
Treatment routine 
Very high levels of adherence to a strict treatment routine are necessary for virologic 
suppression in patients on HAART. This strict treatment routine was identified as a barrier to 
optimal treatment adherence. Treatment fatigue, a Rigid treatment schedule, the fact that it 
Interferes with leisure activities and Forgetfulness contributed negatively to ART adherence. 
 
Treatment fatigue 
Treatment fatigue was mentioned as a barrier to treatment adherence in each one of the FGDs 
and all of the one-on-one interviews. Participants expressed boredom at having to take the 
treatment every day for the rest of their lives and that there was no prospect of ever stopping 
the treatment. The idea of life-long treatment made some participants ambivalent towards 
their medication.  
   I sometimes feel that this thing that I have to take the pills every day does not sit well 
with me, I just get bored and feel like I could just throw them in the bin… - 13 year 
old girl 
Because it has been a while since I started taking the pills, I started when I was 
staying in Mandela at Worcester, but I was not used to them by then. I always ask 
mom and my sister, when I will ever stop taking these pills and my sister says, you 
will take them till you die. So that is why I do not like them. - 13 year old girl 
 
Rigid treatment schedule 
Participants were frustrated by the rigid treatment schedule and felt that there was no 
flexibility allowed in terms of dosing times. This led to non-adherence. Participants were 
concerned that if they took their ARVs after the scheduled times that they may experience 
negative physical effects. Though every effort should be made to take ARVs at the same time 
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every day, the notion that negative effects will result if taken at a different time is not 
necessarily scientifically accurate, yet this was the only message that was communicated to 
them by the health workers. 
Yah, I also miss them sometimes. I am a playful person. So at times I miss my time 
and I do not want to take them after that time because I do not know if they will have 
negative effects after. - 16 year old boy 
 
Interferes with leisure activities  
The younger participants expressed frustration at the fact that they would be playing and then 
be called home to come take their medication. They felt that it imposed on their leisure 
activities.  
When I’m playing it disturbs me. When I’m playing they will call me [to come take my 
medication]. - 14 year old boy 
 
Forgetfulness 
Forgetting to take prescribed medication is common amongst patients on chronic treatment. 
This was also found to be the case amongst these adolescents on HAART who also 
experienced forgetting to take their medication on occasion. This served as a barrier to 
adherence. 
Yes I forget [to take medication] sometimes. - 13 year old girl 
It would help me by reminding me when it is time [to take the medication]. I usually 
forget to take my medication. - 14 year old boy  
 
4.3.5 Patient factors 
The patient-related themes that emerged as impacting negatively on ARV adherence were 
Disclosure, Self-stigma, Adolescent behaviour, Mental health factors and Disease factors.  
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Disclosure 
The literature which has been reviewed highlights the importance of disclosure in treatment 
adherence. In this study, issues around disclosure were identified as barriers to good 
treatment adherence. These were: Dynamics of disclosure, Fear of stigma and discrimination, 
Denial, Being forbidden to disclose and Lack of knowledge about their diagnosis. 
 
Dynamics of disclosure 
The discussion around whether or not disclosure to others impacts on adherence was very 
vibrant. Participants felt that if they would disclose, they would wait until they are in a 
trustworthy relationship and would first try and establish if the other party trusted them too. 
There was also a preference to disclose to close family members only. 
I don’t want to disclose my [HIV] status to my neighbour or to my friends. I want to 
disclose my status only to my family. - 17 year old girl 
If I trust her and if she told me her secrets then I will tell her mine. - 14 year old boy 
 
Some participants however felt that disclosing to others would make the process of going to 
the clinic and taking treatment much easier. 
I think it would be better, because when everybody knows about your status, you do 
not need to hide yourself when taking your treatment and even when you are going to 
the clinic everybody knows. - 20 year old girl 
 
Amongst the younger participants it was common to not disclose in response to parental 
concerns about possible indirect disclosure of parents’ HIV status. Some participants said 
their parents forbid them from disclosing their HIV status. 
Because my mother told me that I must not tell anyone [about my HIV status]. - 10 
year old girl 
  They prohibit us from talking about it [our HIV status]. - 14 year old boy 
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Furthermore, some participants were anxious that their HIV status may be disclosed either 
intentionally or unintentionally. This posed a major barrier to disclosing to significant 
individuals in their lives such as intimate partners. This is particularly pertinent when they 
start engaging in sexual activity as it holds implications for their intimate partner (s). 
…imagine now if you can tell her [girlfriend] about your [HIV] status, and when she 
is angry she burst out in front of everyone. The best way is to keep this to myself. - 16 
year old boy 
 
Fear of stigma and discrimination 
The vast majority of participants cited fear of stigma and discrimination as a reason for not 
disclosing. They felt that others lacked knowledge about HIV and that this may lead to them 
making inappropriate and hurtful remarks. This was a common trend amongst those going 
through early adolescence (10-15 years) as well as those going through late adolescence. 
It could be difficult in the sense that if you have a gathering and you are eyeing a guy, 
that guy will not come to you, knowing that you are positive, that will never happen. - 
20 year old girl 
It’s the fear, you are scared that she will dump you, and she will tell others too. When 
she spreads the news, other girls will not want to be involved with you. They will think 
that you will infect them. - 16 year old boy 
 
Denial 
Denial about being HIV infected was a common phenomenon amongst participants and this 
hindered adherence. This was common regardless of the route of transmission. One 
participant was in denial about her HIV status and struggled to come to terms with the 
manner in which she was infected. She subsequently defaulted ART for a number of months 
and became very ill to the point where she could not care for herself. 
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I was still in denial that I am HIV positive, I was raped by someone very close to me. I 
was raped by a guy staying next door… They did the test and it came positive, I was 
in disbelief, I could not accept the news. I cheated my medication [ART] and lied to 
grandmother. In the mornings on my way to school I throw them away, as I was not 
taking my treatment I was losing weight, and I developed sores on my body. I could 
not do anything for myself, I was unable to even take a bath, and my grandmother was 
bathing me. - 15 year old girl 
 
Denial was also very common amongst peri-natally infected adolescents. They felt that they 
had taken the necessary precautions to avoid contracting HIV horizontally but learnt that their 
efforts were in vain as they were anyway infected as a result of peri-natal transmission. 
Yoh the first year of starting treatment [ART], I took a whole week off from treatment. 
I was in denial, I thought someone would say, it was a lie. I was always careful. I 
learnt about HIV at school so I was forever careful. When I went for testing it was like 
a dream, I could not accept it just like that. - 16 year old boy 
 
Lack of knowledge about diagnosis 
Some participants reported initially being ambivalent towards their medication because they 
were not sure why they were using it. 
And erh I did not love my medication. Why not? Because I don’t know the reason why 
I’m eating this medication. - 22 year old girl 
 
Perceived stigma 
Participants were aware of certain cultural beliefs held by the community about HIV. They 
were not necessarily personally exposed to these stereotypes but they internalised some of 
these beliefs. They experienced Fear of being stereotyped, Fear of intended or unintended 
disclosure and they felt their Treatment routine creates suspicion.  
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Fear of being stereotyped 
Numerous stereotypes were mentioned. Some did not want to disclose as they were aware of 
cultural and social beliefs held by the community about HIV and how it is transmitted. Other 
participants felt that assumptions would be made about how they were infected with HIV. 
  Xhosa people associates HIV with being a whore. - 15 year old girl 
What I am scared of is that, people can label you with all sorts of names. They will   
say do you see that one, she is so and so. They do not even know how you got infected 
in the first place and already they think that they know. - 17 year old girl 
 
Routine creates suspicion 
Some participants expressed that the routine of going to the clinic and taking medication may 
create suspicion amongst their peers and thus lead to unintended disclosure. 
It does not sit well with me, because people will be suspicious, they will have 
questions about my frequent visits to the clinic. That does not make me feel right. - 18 
year old boy 
 If I could drink in the morning only that could help because it would never disturb me 
because some of my friends get suspicious. Why all the time at 7[in the evening] my 
parents always call me inside. What am I doing at home when they call me inside? - 
14 year old boy 
 
Adolescent behaviour 
There were some characteristics unique to adolescents which impacts on their ART 
adherence. These characteristics include Feeling invincible, having Unstructured lives, 
Alcohol usage and Rebellion. These factors were often accompanied by non-disclosure which 
compounded its negative impact on ART adherence.  
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Feeling invincible 
During the interviews it was revealed that some participants felt invincible and were non-
adherent because they thought no harm would come to them if they opted to not take their 
ARVs.  
Sometimes I feel like I am [healthy] like everyone else. Sometimes I feel like I don’t 
want to take them because I always have to drink it. - 14 year old boy 
 
Unstructured lives 
The adolescents in this study reported that they often go to late-night parties and sleep-overs. 
They felt that if they were out late that they could not just leave the social event in order to 
take their medication. Or if they only returned home the next day they would skip their 
treatment. Their unstructured lives presented a major barrier for the participants to adhere to a 
strict treatment regimen. 
There are times when there is a party somewhere and my friends will be attending 
and I also have to go with them. In those instances we come home the following day, 
and I will miss my pills. Those gatherings are fun, I can’t leave fun mos. - 18 year old 
boy 
  Sometimes, like holiday like December like its few party. And so like if I was at a 
party with friends, like maybe I am whatever place with my friends but my friends did 
not know I was HIV positive. So when it was 9 o’clock it was difficult to just leave. So 
I would just think argh, so what if I don’t take them, nothing will change I will just 
take them on another day. - 15 year old girl 
 
Alcohol use 
Participants reported alcohol use as a barrier to adherence to ART. They were informed that 
one cannot use ART and alcohol together. Thus, instead of not using alcohol at a party, they 
would rather opt to not use their ART for that particular evening.  
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F: What happens if you drink a little bit too much alcohol? Do you still drink 
your treatment?  
P1: No, because the doctors said there is going to be trouble when you mix drugs 
and alcohol  
F: So what happens if you were maybe drinking beer the Friday night, Saturday 
and Sunday night? 
P1: Then you don’t drink the pills. - 18 year old boy 
 
Rebellion 
Key informants reported that adolescents on ART, just like other adolescents, are rebellious 
during this stage of their lives and this is further complicated by being on ART. This, she 
suggested, posed a challenge to ART adherence. 
 Okay uhm it’s a challenge because uhm some of them are in that stage because they 
are teenagers of being rebellious so now there is this thing of ARVs. If maybe we got 
some who started when they were 5 years but once they reach that age they are very 
negligent because it is like to me they are kids at times, they are adults and they are 
kids at the same time. - K.I.  
 
Mental Health 
The mental health factors which impacted negatively on ART adherence were Shame at mode 
of HIV transmission, Anger at mother for peri-natal transmission of HIV, Depression, 
Suicidal ideation, Loneliness and Hopelessness.  
 
Shame at mode of HIV transmission 
One participant felt intensely ashamed at the fact that she was infected through being sexually 
assaulted. This led to her not being adherent to her treatment and as a result she fell very ill. 
 
 
 
 
51 
 
Eh when I first found out I was HIV positive it was difficult, it was not easy. I feel like 
I’m dirty. I embarrass my family because I am young because I am HIV positive and 
there was no one explaining to me as a positive person that this and this. - 15 year old 
girl 
  No… yes… I think I was 14 years old I was raped with my neighbour I call him uncle 
but I don’t tell my aunt I tell my grandmother because I was scared and shy and 
embarrassed. - 15 year old girl  
 
Anger at mother for peri-natal transmission of HIV 
Many of the peri-natally infected participants expressed anger at their mothers who in some 
cases were deceased. They felt that if their mothers took ART then they possibly would not 
have been burdened by needing chronic medication. Only one participant implicated his 
father in his disease profile. 
Because somebody told me, because my aunty had told me once. She said what made 
me to become HIV, it’s because my mother and my father had the disease so my 
mother did not drink the pills [ART] so that I could not have HIV. My mother did not 
drink it so that is why I become HIV positive. - 14 year old boy 
  Yes because I ask myself why did my mom not drink those pills [ART], now I could be 
better like everyone. - 14 year old boy 
 
Depression 
Depressive symptoms were very common amongst participants especially older participants. 
Many participants said they had experienced thoughts of wanting to die. 
Iyoh, I wasn’t feel happy because sometimes I was try to kill myself. - 22 year old girl 
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Suicidal ideation/intent  
One participant mentioned how she had an incomplete suicide attempt following numerous 
struggles related to her HIV status. 
One day it was a Sunday, I was still staying with my aunt, when everybody was 
preparing to go to church. I said to them I was not feeling well. They left, and I took 
all my pills [ART] and mixed them, I was trying to kill myself, I had enough of life and 
challenges… I took all of the pills and drank them with milk. I lied on the bed. My 
brother came and he called an ambulance. I was admitted and the nurses drained the 
pills and I recovered. -  22 year old girl 
 
Loneliness 
Adolescence is characterised by a desire to fit in. This was no different amongst the 
participants in this study. Many of the younger participants felt lonely and as though they do 
not fit in because they are on chronic medication. They considered this to be an abnormal 
state of being. 
F: When you say you want to be like everyone else, what does that mean?  
P: To be like a normal person, when I am taking these ARVs I don’t feel like a 
normal person because everybody does not drink these pills. I feel like I am 
the only one here that drinks these pills. - 14 year old boy 
Is that it is me alone at my home that is drinking the medication and that it makes me 
… it makes me feel very lonely. - 14 year old boy 
 
Hopelessness 
It was common for participants to have dreams and aspirations and this served as a facilitator 
to treatment adherence. However some of them cited feeling extremely hopeless and this 
impacted negatively on their ART adherence. 
Not now like last year a lot because I feel bored and I feel no future. I am dirty I feel 
like I take the pills to the toilet and flush [the pills]. - 15 year old girl 
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Disease Factors 
Some of the barriers to adherence were directly linked to the disease. These were:  Diagnosis 
of HIV taken lightly and Not experiencing any physical benefit of treatment. 
 
Diagnosis of HIV taken lightly 
One of the participants reported that she did not think a diagnosis of being HIV positive was 
to be taken seriously until she fell ill and realised the importance of being on ARVs. 
I was 14 years old but when I first found out [that I am HIV positive]. It was in June 
2012. But I had no problem and I did not take it seriously. Like, they came to school 
to test us and they said I was HIV positive and they gave me a letter to take to the 
clinic. I never bothered doing that. I did not care. - 18 year old girl 
 
No physical benefit of treatment 
Some of the younger participants felt that they did not experience any physical benefit from 
being on ART.  
I feel but I am not believing it that they are helping me but I believe that I am just 
drinking them to know that I will be fine. That’s all.  I don’t believe that it will heal 
me. - 14 year old boy 
Because I drink them everyday nothing is happen to me.  I always drink it and I stay 
the same. Nothing changes. - 14 year old boy 
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4.4 FACILITATORS OF ADHERENCE 
The findings from the interviews highlighted many barriers to adherence but it also 
highlighted factors which motivated participants to remain adherent to their ART regimen. 
This section will focus on the facilitators of adherence. The reported facilitators to ART 
adherence (Table 4.3) were organised according to the following main categories:  
 Support system; 
 Patient factors; 
 Disclosure; 
 Disease factors; and 
 Daily routine  
 
 
 
Table 4.3. Facilitators of adherence 
Category Codes 
Support system Being part of a HIV support group 
Family support 
Support from clinic staff 
Patient factors Goals/ambitions 
Spiritual strength 
Strong leadership qualities 
Disclosure Being disclosed to 
Support from friends 
Disease factors Fear of AIDS and death 
Seeing others live well with HIV 
Daily routine Reminders from TV programmes 
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4.4.1 Support System 
A strong support system/network proved vital for these young people on ART. They spoke 
fondly of those who support them on a daily basis when they are discouraged to take their 
treatment or to attend clinic visits. This support network was made up of HIV support groups, 
Family support and Support from clinic staff. 
 
Being part of a HIV support group 
In general, those participants who were part of a support group were a lot more outspoken 
about their HIV status and a lot more knowledgeable. Very few participants however were 
part of a support group. Even though participants said it helped them to be part of a support 
group, when viewing their clinic notes, they did not necessarily always have better adherence 
than those participants who were not part of the support group. Those who did attend the 
local support group (Ayabonga) also said they received help from some of the adult 
supervisors to collect their medication. 
I ask mummy here at Ayabonga, she comes and collects my pills… - 18 year old boy 
 
Family support 
Those participants who still had a biological mother identified very strongly with her and 
found it to be a very supportive relationship especially if the mother was also HIV positive 
and on ART. Some also identified siblings to be important in their support structure and they 
often reminded them to take their medication. 
Okay we are four, it’s me, my mom, and my 2 sisters. But I am close to my mom. Me 
and my big sister we quarrel a lot, even out of nothing. She knows about my treatment 
but when we have fights she doesn’t say anything about it, even when I am tired of 
taking it they encourage me to continue. They always check if I take my treatment and 
they will notice that I am not taking it. We are such a close family but I am closer with 
my mother. - 16 year old boy 
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Support from clinic staff 
Participants found some staff members to be very understanding and supportive. Even when 
they were noticed by staff members in the community they would encourage them to 
continue their treatment. Participants really appreciated this gesture. 
I like the fact that most of the staff are people that I know and they like to ask me 
about my treatment, they take concern about my appointments. They also ask my 
mother “Is your child still taking his medication?”  And she will tell them if I stopped. 
- 16 year old boy 
 
4.4.2 Patient Factors 
There were a number of factors on an individual level that assisted participants in being 
adherent to their ART. These included having Goals and ambitions, Spiritual strength and 
having Strong leadership qualities. 
 
Goals and ambitions 
Even though participants were burdened with a chronic and highly stigmatised illness they 
still had the will to live and all of them mentioned future goals and ambitions. These goals 
were academic, financial and family-related. 
Eh when I finish school I want to become a teacher and have a wife with two children 
and pay mother for everything she has done for me and be independent. To have a 
car, a house to show that I am a grown man now and I am working. - 16 year old boy 
 
Spiritual strength 
Participants found their journey with HIV and ART very difficult albeit to different degrees. 
Many found strength in their belief in a higher power and attributed their perseverance with 
ART to their relationship with a higher spiritual authority. 
 
 
 
 
57 
 
This did not sit well with me, since I grew up saved, I was praying to God for strength 
and I knew that whatever was happening in my life at that moment it was going to 
pass. - 22 year old girl 
 
Strong leadership qualities 
Some of the older participants felt a lot peer pressure to go along to parties and other social 
events which often meant that they would not be able to take their treatment on that particular 
day. Others however were strong enough to not go along with the crowd and to act 
responsibly about their academics and treatment. 
I do not go with the flow. Crowds have influence, so when my friends invite me to join 
them, I tell them to go and enjoy themselves, I will follow them later. - 18 year old boy 
 
4.4.3 Disclosure 
Disclosure can be considered two-pronged; firstly one needs to be disclosed to and secondly 
you may choose to disclose to someone else. Some respondents found both of these to be 
useful for treatment adherence. 
 
Being disclosed to 
Many participants reported that their adherence had improved once their HIV status had been 
disclosed to them and they understood why they had to take this chronic medication. Some of 
the older adolescents had been taking ART for a very long time before they knew what the 
medication was for which made them averse to taking the medication. However once they 
were disclosed to, they were more accepting of the fact that they needed ART. 
…because I am HIV positive and they didn’t tell me I’m HIV positive and I get HIV 
positive with my mom. She tried but she didn’t plan about this and also she tried to 
make me understand but end of the time I was understand and then I was just 
welcome this medication. - 22 year old girl 
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Support from friends  
Some participants identified best friends whom they felt very comfortable speaking to. These 
friends would remind them to take their medication and even accompany them to the clinic. 
Yah because I feel like I am free, even when he visits my place or I visit his place I 
feel free to take my medication. When I am sleeping over at his place, when I say I am 
going to take my pills he understands and even remind me some days. - 18 year old 
boy 
 
4.4.4 Disease Factors 
Participants identified factors which had a direct bearing on the disease which helped them to 
be more compliant with their medication. These were: Fear of AIDS and death and Seeing 
others live well with HIV. 
 
Fear of AIDS and death 
Respondents feared the development of opportunistic infections, extreme pain and death. 
Some of them had already previously been admitted to hospital or had a severe opportunistic 
infection.  
What encourages me [to take my ART], is the fear of illness. I am scared of pains, 
when you are not complying with your treatment you fall sick and I do not want to 
lose weight. I want to remain healthy, and I do not want to look different from other 
people. - 18 year old boy  
  No, I will take it [ART]. I do not have a choice. I do not want to be sick, and I do not 
want to die. I want to die of accident not of AIDS, I do not want to be hospitalized 
because of AIDS, and I do not want that. - 16 year old boy 
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Seeing others live well with HIV 
Some participants witnessed how parents and others known to them were on ART and were 
able to continue with their lives despite having a chronic illness. Some of these people were 
their role-models and they tried to imitate their example. 
Okay what encourages me [to take my ART] is the fact that there are too many people 
who are HIV positive, even around here. My coach has it. I didn’t believe it, I told 
myself that I still have a life ahead; I can grow and be old as coach. - 16 year old boy 
 
Daily Routine 
Participants described events in their daily routine which served as a reminder to take their 
medication. One such a reminder was the popular daily television programme, “Generations”. 
Participants used the time of this show as a reminder that they needed to take their 
medication. This however was only effective when evening doses of ART had to be taken. 
Maybe it is the two of us, watching Generations. In my mind there is something that 
tells me to take my pills. - 13 year old girl 
 
4.5 SUMMARY 
The barriers to treatment adherence were identified as: conflict between school and clinic 
times, strained relationships with teachers, difficult family dynamics. In addition there were 
barriers related to the health care services rendered such as the quality of care received, 
strained patient-staff relations, unhappiness about service delivery and the patient flow at the 
health facility. Medication side effects, pill burden, treatment fatigue and the rigid treatment 
routine were also identified as having a negative impact on treatment adherence. Dynamics 
which occur at an individual level also contributed significantly to non-adherence such as 
lack of disclosure, symptoms of depression, perceived stigma, behaviours unique to 
adolescents and feeling ashamed about the mode of transmission. Of note was how 
respondents feared unintended disclosure from those who may be aware of their status, this 
impacted on their willingness to disclose.  
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The facilitators to adherence included receiving support from family and friends they have 
disclosed to as well as motivation received from health care workers. Participants also had 
goals and ambitions and derived strength from their religious beliefs. In addition, respondents 
were encouraged by seeing how healthy other HIV positive people are. 
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CHAPTER FIVE 
DISCUSSION 
5.1 INTRODUCTION 
In this chapter I will present a discussion on the findings of the study (barriers and facilitators 
of adherence) in the light of existing literature.   
 
5.2 BARRIERS TO ADHERENCE 
School factors 
School commitments, communication with school teachers and negative teacher attitudes 
were found to play a significant role in both accessing the clinic, disclosure and adherence to 
ART. Participants often expressed feeling conflicted between school commitments and the 
need to attend clinic appointments. In addition, the need to communicate attending regular 
clinic visits to teachers posed a significant barrier to attending regular clinic follow ups as 
they feared unintended disclosure which may potentially lead to stigma and discrimination. 
The findings of the current study are in keeping with the literature which suggests that 
mainstream schooling may not necessarily always have a positive impact on adherence. In 
this study the routine of schooling also made clinic visits difficult and some participants felt 
that their frequent absences may lead to unintended disclosure of their HIV status. It is well 
documented that if adolescents disclose their status to a trustworthy person/people they are 
more likely to receive help in the form of knowledge and resources to help them cope with a 
HIV diagnosis and to access and remain in HIV care (WHO, 2013). This fear of unintended 
disclosure in the school environment may thus lead to poor adherence.  
 
Social factors 
A lack of financial support and negative household dynamics were found to have a negative 
impact on ART adherence. Of interest in this study was that none of the participants 
mentioned financial support as being important for basic necessities such as food as was 
highlighted in studies by Cotton et al. (2010) and Cluver (2015). Financial support was 
however identified as being able to assist in paying for private health care. A large number of 
participants expressed the desire to access private health care as a means of avoiding 
 
 
 
 
62 
 
disclosure and also avoid spending long periods of time at the health facility. The findings of 
the study are thus in keeping with the literature.  Cotton et al. (2010) report from their 
qualitative enquiry with 26 adolescents in the Western Cape province that participants felt 
that their lives would be significantly improved if they received support in the form of 
money. Cluver et al. (2016) also suggest that financial support may be important in adults 
adhering to ART. Although the reasons supplied by participants in this study for needing 
financial assistance were unconventional, it was clear that financial support would make 
adherence to ART easier. 
 
In the current enquiry, negative household dynamics had a profoundly detrimental effect on 
ART adherence. Participants cited negative relationships with non-biological caregivers as a 
barrier to adhering to ART with some orphans even saying they defaulted ART in an attempt 
to end their lives and be with their deceased biological parents. Furthermore, adolescence is 
characterised by a desire to fit in. Some respondents reported feeling like outcasts amongst 
their immediate family as a result of being HIV positive. Respondents expressed that they 
would feel a greater sense of belonging amongst their relatives if they were HIV negative. 
The findings are in keeping with the literature that identifies household dynamics as playing a 
pivotal role in adherence to ART. Brown and Lourie (2000) assert that parenting and family 
dynamics play a key role in enabling adolescents to adjust to their HIV status. Furthermore, 
Cotton et al. (2010) confirmed a positive association between good parenting/family 
relationships and adherence to HIV care by adolescents.  
 
Given that there are so many factors in the household which may negatively impact on ART 
adherence, it therefore stands to reason that perhaps family dynamics need to be probed by 
health care workers and assessed prior to ART initiation and on an ongoing basis but 
especially in adolescents who have poor adherence. This is in keeping with a suggestion by 
Williams et al. (2006) that family dynamics and family characteristics should be evaluated 
prior to initiating ART in adolescents who acquired HIV infection peri-natally.  
 
From this research enquiry it was also clear that an isolated social intervention would not be 
sufficient in aiding with adherence but that improving on a combination of factors would. 
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This is in line with findings from Cluver et al. (2016:79) that a “…combination of cash and 
care social protection was associated with reduction in past-week non-adherence…” 
 
Health Services Factors 
Numerous factors related to the health services rendered were found to have an adverse 
impact on appointment and ART adherence. Long waiting times and missing or misplaced 
files had a profoundly negative impact on treatment adherence. In particular, long waiting 
times were mentioned by all participants as a deterrent to adhering to treatment and clinic 
appointments. All participants mentioned long waiting times as a barrier to remaining 
adherent to treatment especially when they still had to honour school commitments. These 
findings are in keeping with those by Ferrand (2016) which recommends that adolescent 
ART services need to be youth-friendly and consisting of amongst others a youth-friendly 
waiting area, evening clinics and a dedicated clinic day. In addition, participants feared that 
the flow of patients at this health facility may lead to unintended disclosure of their HIV 
status. This is because the area in which you waited in the clinic was indicative of the 
treatment you were collecting which could thus lead to stigmatisation. 
 
Missing and misplaced files also served as a major barrier to adhering to ART as adolescents 
would be told by clinic staff to return to the clinic on a different day to collect their 
medication. Adolescents experienced this as extremely stressful. It may potentially be 
dangerous too since adolescents, particularly peri-natally infected adolescents, may be 
heavily treatment experienced and thus not be able to accurately recount their disease and 
treatment history making accurate prescription difficult. Existing literature on adolescent 
ART adherence does not mention missing files as a barrier. This may be because a lot of the 
data on ART adherence amongst adolescents come from a first world setting where electronic 
medical records are often used. 
 
Furthermore, patient-staff relations had the potential to impact on adherence either positively 
or negatively. Some health care workers had negative attitudes towards patients yet some 
respondents were sympathetic toward this and ascribed it to staff experiencing a lot of stress 
and taking it out on their patients. In addition, poor quality of care had a profoundly negative 
impact on ART adherence. We found that patients with good adherence would receive 
preferential care at the health facility and those who had defaulted would have to wait longer 
before they are assisted in addition to being verbally abused by health care workers. Patients 
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found this sort of treatment to be incredibly frustrating and this served as a deterrent to going 
back to the clinic for help if they had defaulted ART. The findings are in keeping with the 
literature by Chesney (2000) and Hudelson and Cluver (2015) who found that the health care 
system and patient-provider relationships played a significant role in adolescents remaining 
adherent to ART. 
 
The key informant interviews revealed that often the unique attributes of adolescents were 
not completely understood by health care workers and that this impacted on service delivery 
to this group and resultant adherence. They were of the opinion that the health care system 
should be set up in such a way so as to focus on the unique needs of adolescents. Ferrand 
(2016) also recommends that ART care at youth-friendly health facilities should ideally be 
provided by trained health care workers.   
 
Therapy-related factors 
Some of the major barriers to treatment adherence were related to the medication and the 
treatment routine.  As discussed in the literature review, very high levels of adherence to a 
rigid treatment routine are required for virological suppression in patients on HAART 
(Bekker et al., 2008). Treatment fatigue was mentioned as a profoundly significant barrier to 
adherence by all participants. Participants in this study found the treatment routine associated 
with ART extremely rigid and were frustrated by the fact that apparently no leniency was 
allowed. This is in keeping with the literature by Merzel et al. (2008) that identified regimen 
fatigue as a major factor impacting on older adolescents’ ability to remain adherent to a 
treatment regimen. There was even a suggestion from the older adolescents in this study that 
having ART-free weekends would greatly improve adherence. This may indeed be possible 
as recent findings from the BREATHER trial (Butler et al., 2016) found that a five-day 
Efavirenz-based regimen was not inferior to a seven-day regimen in maintaining viral load 
suppression and it reduced toxicity associated with long-term exposure.  
High pill burden was also identified as a barrier to treatment adherence especially amongst 
those on a second line ART regimen which usually includes the Protease Inhibitor, Alluvia, 
which has to be taken twice daily. The Alluvia tablet is a very unpalatable tablet and has 
unpleasant side-effects. This also contributes to poor adherence. This too is in keeping with 
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the literature that says high rates of non-adherence to ART amongst adolescents highlight the 
need to make treatment regimens simpler and more tolerable (Penazzato et al., 2015). Higher 
rates of defaulting were reported from those on second line ART. This is in keeping with 
outcomes from the REACH study which found an association between treatment adherence 
and pill burden (Murphy et al., 2010). 
 
Patient factors  
The dynamics of disclosure played a pivotal role in ART adherence amongst these 
participants. The majority of participants preferred selective disclosure in other words they 
chose to disclose their HIV status to some people but not to others. However, some 
participants felt that if everyone knew their HIV status it would make the process of 
accessing the clinic and taking ART a whole lot easier. Many participants chose not to 
disclose as they feared rejection, stigma and discrimination and this had a dramatic influence 
on adherence. Furthermore, some of the younger participants did not disclose in response to 
parents who forbid them to talk about their HIV status. This may be because if an adolescent 
discloses their HIV status they may also indirectly be disclosing their parent(s) HIV status. 
The findings are in keeping with the outcomes of a workshop held in South Africa that found 
that adolescents preferred to keep their status to themselves (WHO, 2013). 
 
Furthermore, adolescence is a transitional phase which may be characterised by defying 
authority and a sense of invincibility. Many participants felt that no harm would come to 
them should they not take their medication. Their decision making thus seemed to favour 
more immediate benefits than long term reward. In addition, the lack of structure such as 
attending late-night parties and sleep-overs made it difficult to adhere to a rigid, daily 
treatment regimen. These attributes together with alcohol usage were all associated with poor 
adherence. These issues were compounded by non-disclosure and a combination of any one 
of these factors proved particularly detrimental to ART adherence. These findings correlate 
with the literature. Hoare (2016) found that HIV positive youth had poor cognitive inhibition 
and had poor executive function which may impact on daily activities such as decision 
making. All these characteristics are necessary to navigate through adolescence, to be less 
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impulsive and to make good decisions about their health such as remaining adherent to an 
ART regimen. 
 
Depression, anger and loneliness also stood out prominently as having a negative influence 
on adherence. A review of mental health of HIV positive youth suggested that they 
experience emotional and behavioural problems, including psychiatric disorders, at higher 
than expected rates, often exceeding those of other high-risk groups (Mellins, 2013; Hoare, 
2016).  This is in keeping with the literature by Uthman (2014) that found that patients with 
depressive symptoms were 42% less likely to achieve optimal adherence to a HAART 
regimen. 
 
5.3 FACILITATORS OF ADHERENCE 
 
Support system 
Receiving support from HIV support groups, health care workers and family members was 
perceived to have a positive influence on adherence. Participants with an HIV positive parent 
identified very strongly with that parent and also reported receiving support from siblings to 
remain adherent to their ART. These findings are in keeping with the literature by Sharer et 
al. (2016) that examined the relationship between parent and sibling support amongst 
children affected by HIV and AIDS. Sharer et al. (2016) found that support from siblings was 
a significant source of support and that it was positively associated with mental health. This 
(good mental health) in turn may have a positive impact on adherence.  
 
The current study also found that participants had improved adherence once their HIV status 
had been disclosed to them and also received support from friends to whom they have 
disclosed their HIV status. These findings are in keeping with the literature from WHO 
(2013) that says if adolescents disclose their status to a trustworthy person/people they are 
more likely to receive help in the form of knowledge and resources to help them cope with a 
HIV diagnosis and to access and remain in HIV care. Sharer et al. (2016) also suggest that 
further research is required to determine how social support adds to resilience amongst 
children living in settings with a high burden of HIV such as South Africa. 
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Patient factors 
Having goals and ambitions served as a motivating factor for remaining adherent to ART. 
Having spiritual strength and strong leadership qualities was also associated with good 
adherence. Bhana et al. (2016) did an enquiry into resilience amongst peri-natally infected 
HIV positive adolescents in South Africa. Some of these factors on an individual level which 
influenced resilience included having self-esteem and self-regulation. The findings of our 
research are thus in keeping with this literature. Though participants had numerous household 
stressors as well as challenges on an individual level, many reported having goals and 
ambitions and being strong-willed such that they are not influenced by peer pressure.  
 
5.4 LIMITATIONS OF THE STUDY 
The study had the following limitations: the researcher could not explore the impact of the 
employment sector as none of the participants were employed. The data did not sufficiently 
explore the impact of social protection on adherence. The researcher did not adequately 
explore the impact of transitioning from paediatric to adult care. 
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CHAPTER SIX 
 
CONCLUSIONS AND RECOMMENDATIONS 
                                                        
6.1. CONCLUSIONS 
Very little is known about the factors which influence adherence to ART amongst 
adolescents. In addition, very limited research is available which describes these factors from 
the perspective of adolescents and young people. A qualitative study thus enabled the 
researcher to explore these factors from the perspective of the participants. The study sought 
to explore the factors that influence adherence to ART amongst adolescents in a primary 
health care clinic in a low socio-economic, urban setting in Cape Town. An exploratory 
qualitative design was employed which revealed many complexities associated with 
attempting to remain adherent to an often complex ART regimen, more so for adolescents 
who have very unique physiological and psychological attributes. The data revealed that 
school commitments made adherence to ART and clinic appointments very difficult as many 
a times there is conflict between school programmes and clinic times. This is because 
participants often had to attend afternoon classes and by the time they got to the clinic it 
would be closed. In addition, strained relationships with teachers made the process of 
accessing the clinic very difficult. We also found that household dynamics played a crucial 
role and ill-treatment by non-biological care givers had a profoundly negative impact on 
treatment adherence. 
 
It was apparent that some participants were disappointed with the service delivery received at 
this health facility; missing or misplaced files and long waiting times stood out prominently 
as having a negative impact on ART adherence. All participants in this research study were 
tremendously frustrated about the long waiting times at the clinic. Furthermore, participants 
were very concerned that the flow of patients at the health facility may lead to unintended 
disclosure of their HIV status and this was offered as a reason for not following up for clinic 
appointments. In addition the quality of care at the facility came under criticism with some 
reporting verbal abuse, inappropriate management of health complaints and reports that those 
with good adherence received preferential care. All these discouraged participants from 
following up for clinic visits.  
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Therapy-related factors and in particular pill burden, a rigid treatment schedule and treatment 
fatigue was probably amongst the most common barriers associated with poor adherence. 
Treatment fatigue affected all participants and was the most prominent barrier to adhering to 
treatment. The development of more innovative drug formulations such as injectable ART 
and other long-acting ART may aid in improving ART adherence in this group.  
 
Issues around disclosure in most cases had a negative impact on adherence however some 
participants reported receiving support from friends they had disclosed their HIV status to. 
Disclosure was found to be a very dynamic process. Four decades into the epidemic, HIV is 
still a highly stigmatised illness and many respondents in this study highlighted a fear of 
discrimination and stigma - both overt and perceived stigma - as barriers to remaining 
adherent to ART.  Interestingly many of the younger participants reported being forbidden by 
their parents/caregivers to disclose their HIV status to others. This may be related to parental 
fears of indirect disclosure of parental HIV status.  
 
Finally, unique adolescent attributes such as having unstructured lives and a sense of 
invincibility also made treatment adherence very difficult. This may be compounded by 
alcohol usage and non-disclosure. And lastly, sadness, depression and loneliness had a 
profoundly negative effect on treatment adherence in this cohort. 
 
6.2. RECOMMENDATIONS 
Following data collection and an in-depth analysis of the wealth of data collected, the 
following recommendations are made for health care workers, ART users, parents/caregivers 
of HIV positive adolescents, policy planners/implementers, school teachers and the 
community. The researcher is of the opinion that these recommendations will go a long way 
in improving adherence to ART amongst HIV positive adolescents.   
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Health Care Workers 
Health care workers need to be aware of the barriers that influence adherence amongst 
adolescents and receive training specific on how to deal with HIV positive adolescents and be 
sensitive to their needs. They should enquire about symptoms of anxiety and depression at 
each visit and promptly refer all patients who present with these symptoms to a mental health 
care practitioner. All patients and caregivers should be treated equally and with dignity 
regardless of their level of adherence and patients and caregivers should not be verbally 
abused by health care workers. Every attempt should be made not to lose or misplace 
files/patient documents. Health care workers should enquire about disclosure, sexual partners 
and household dynamics at each visit. 
 
ART users 
ART users should always consider disclosing their HIV status to at least one trustworthy and 
reliable person. They should seek out sources of support such as HIV support groups and 
spiritual groups to facilitate their adherence to ART.  
 
Parents/caregivers 
Parents and caregivers need to be supportive of their HIV positive adolescents and/or foster 
children. They need to enquire from adolescents regarding their treatment adherence and be 
alert to symptoms of depression and anxiety. 
 
Policy planners/implementers 
Policy planners and implementers need to design and implement adolescent-specific medical 
stationery/tools that address the barriers associated with adherence. They should prioritise, 
plan and facilitate the implementation of adolescent-friendly health facilities and systems 
such as more flexible clinic operating times, evening and/or weekend clinics and have 
dedicated clinic days for adolescents. Policy makers should facilitate the implementation of 
peer support groups as well as text messaging services to remind clients about their clinic 
dates. The roll-out and funding of long-acting ART should be prioritised. Policy makers 
should motivate for mandatory annual mental health screening for example an annual visit to 
the psychologist as well as mandatory evaluation of family dynamics prior to ART initiation 
and annually thereafter. 
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School teachers 
School teachers need to be aware that there are learners infected and affected with HIV at 
schools and therefore address the topic with sensitivity. They should provide ongoing 
education about HIV prevention strategies and be supportive of learners who require regular 
clinic visits. School teachers should provide evidence-informed teaching about HIV and 
avoid spreading messages which may have discriminatory undertones. 
 
Community 
The community should facilitate programmes to decrease HIV-related stigma and 
discrimination. The community should also be supportive of those on ART and encourage the 
formation of support groups  
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APPENDICES 
Appendix A: Information sheet for parents 
University of the Western Cape                
                                            School of Public Health 
 
 
PARTICIPANT INFORMATION SHEET FOR PARENTS/GAURDIANS 
Project Title: Adherence to antiretroviral treatment amongst adolescents in a low socio-
economic urban setting in Cape Town, South Africa. 
What is this study about?  
This is a research project being conducted by Lee-Ann Davids at the University of the 
Western Cape.  We are inviting your child/dependant to participate in this research project 
because he/she is currently between the age of 10 and 19 years and accessing Antiretroviral 
treatment (ART) at this facility. The purpose of this research project is to try and identify 
what are the reasons or circumstances for adolescents to not remain compliant on their ARTs. 
We are hoping that if we have this information that assistance can be provided to patients and 
staff members to enable better compliance to medication. 
What will your child/dependant be asked to do if he/she agrees to participate? 
He/she will be asked to participate in a group discussion and possibly a one-on-one interview 
with the researcher and a translator if required. If he/she wishes to participate in the study 
he/she will be asked to sign a consent form. The interviews will last approximately 
45minutes. The participants will be asked questions about things like their family support, 
schooling or work situation; their experience with ART and the clinic staff. The interviews 
will be conducted in a quiet room at the clinic at a time that suits them best.  
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Would their participation in this study be kept confidential? 
The researcher undertakes to protect their identity and the nature of their contribution at all 
times. This study will use focus groups therefore the extent to which their identity will remain 
confidential is dependent on participants’ in the focus group maintaining confidentiality.  In 
addition, there may be some conditions under which confidentiality will be broken such as 
when the researcher is made aware of criminal activity which participants have been or are 
currently still victim of. Under these conditions, the researcher is compelled to break 
confidentiality and to report the criminal behaviour to the relevant authorities. If this situation 
does arise, the researcher will make the participant aware of her intention to break 
confidentiality. 
What are the risks of this research? 
There may be some risks from participating in this research study. All human interactions and 
talking about self or others carry some amount of risk. We will nevertheless minimise such 
risks and act promptly to assist your child if they experience any discomfort, psychological or 
otherwise during the process of your participation in this study. Where necessary, an 
appropriate referral will be made to a suitable professional for further assistance or 
intervention.   
What are the benefits of this research? 
The benefits to your child includes that they may find it supportive to meet and talk to other 
participants their own age that may be facing similar situations to theirs. If we are able to 
identify and explore the issues which contribute to poor compliance then your child may 
benefit if we act on this information and put measures in place to try and optimise the care of 
adolescents on ARTs 
 The results may help the investigator learn more about ART non-compliance and what leads 
to this problem. We hope that, in the future, other people might also benefit from this study 
through improved understanding of these issues.  
Does your child have to be in this research and may they stop participating at any time?   
Their participation in this research is completely voluntary.  They may choose not to take part 
at all. If your child decides to participate in this research, he/she may stop participating at any 
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time.  If they decide not to participate in this study or if they stop participating at any time, 
they will not be penalized or lose any benefits to which they otherwise qualify.  
What if my child has questions? 
This research is being conducted by Lee-Ann Davids a Masters student at the School of 
Public Health at the University of the Western Cape.  If you have any questions about the 
research study itself, please contact Lee-Ann Davids at +27722333877 or at 9 Melina Street, 
Rosendal, Durbanville, 7550. Alternatively you may send an email to 
3409645@myuwc.ac.za 
Should you have any questions regarding this study and your child’s rights as a research 
participant or if you wish to report any problems you have experienced related to the study, 
please contact:  
  
Prof Helen Schneider 
School of Public Health  
Head of Department 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
soph-comm@uwc.ac.za     
 
Prof José Frantz  
Dean of the Faculty of Community and Health Sciences  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za     
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Appendix B: Participant information sheet 
University of the Western Cape                     
School of Public Health 
 
 
PARTICIPANT INFORMATION SHEET 
Project Title: Adherence to antiretroviral treatment amongst adolescents in a low socio-
economic urban setting in Cape Town, South Africa. 
What is this study about?  
This is a research project being conducted by Lee-Ann Davids at the University of the 
Western Cape.  We are inviting you to participate in this research project because you are 
currently between the age of 10 and 19 years and accessing Antiretroviral treatment at this 
facility. The purpose of this research project is to try and identify what are the reasons or 
circumstances for adolescents to not remain compliant on their ARTs. We are hoping that if 
we have this information that assistance can be provided to patients and staff members to 
enable better compliance to medication. 
What will I be asked to do if I agree to participate? 
You will be asked to participate in a group discussion and possibly a one-on-one interview 
with the researcher and a translator if required. If you wish to participate in the study you will 
be asked to sign a consent form. If you are younger than 18years old, both you and your 
parent/guardian will have to sign the form. The interviews will last approximately 45minutes. 
You will be asked questions about things like your family support, schooling or work 
situation, your experience with ART and the clinic staff. The interviews will be conducted in 
a quiet room at the clinic at a time that suits you best.  
Would my participation in this study be kept confidential? 
The researcher undertakes to protect your identity and the nature of your contribution at all 
times. This study will use focus groups therefore the extent to which your identity will remain 
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confidential is dependent on participants’ in the Focus Group maintaining confidentiality.  In 
addition, there may be some conditions under which confidentiality will be broken such as 
when the researcher is made aware of criminal activity which participants have been or are 
currently still victim of. Under these conditions, the researcher is compelled to break 
confidentiality and to report the criminal behaviour to the relevant authorities. If this does 
happen, the researcher will make you aware of her intentions. 
What are the risks of this research? 
There may be some risks from participating in this research study. All human interactions and 
talking about self or others carry some amount of risks. We will nevertheless minimise such 
risks and act promptly to assist you if you experience any discomfort, psychological or 
otherwise during the process of your participation in this study. Where necessary, an 
appropriate referral will be made to a suitable professional for further assistance or 
intervention.   
What are the benefits of this research? 
The benefits to you include that you may find it supportive to meet and talk to other 
participants your own age that may be facing similar situations than you are. If we are able to 
identify and explore the issues which contribute to poor compliance then you may benefit if 
we act on this information and put measures in place to try and optimise the care of 
adolescents on ARTs 
The results may help the investigator learn more about ART non-compliance and what leads 
to this problem. We hope that, in the future, other people might also benefit from this study 
through improved understanding of these issues.  
Do I have to be in this research and may I stop participating at any time?   
Your participation in this research is completely voluntary.  You may choose not to take part 
at all. If you decide to participate in this research, you may stop participating at any time.  If 
you decide not to participate in this study or if you stop participating at any time, you will not 
be penalized or lose any benefits to which you otherwise qualify.  
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What if I have questions? 
This research is being conducted by Lee-Ann Davids, a Masters student at the School of 
Public Health at the University of the Western Cape.  If you have any questions about the 
research study itself, please contact Lee-Ann Davids at +27722333877 or 9 Melina Street, 
Rosendal, Durbanville, 7550. Alternatively send an email to 3409645@myuwc.ac.za 
 
Should you have any questions regarding this study and your rights as a research participant 
or if you wish to report any problems you have experienced related to the study, please 
contact:  
 Prof Helen Schneider 
School of Public Health  
Head of Department 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
soph-comm@uwc.ac.za     
 
Prof José Frantz  
Dean of the Faculty of Community and Health Sciences  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za     
 
 
 
 
88 
 
Appendix C: Information sheet for key informants 
University of the Western Cape                     
School of Public Health 
 
 
INFORMATION SHEET FOR KEY INFORMANTS 
Project Title: Adherence to antiretroviral treatment amongst adolescents in a low socio-
economic urban setting in Cape Town, South Africa. 
What is this study about?  
This is a research project being conducted by Lee-Ann Davids at the University of the 
Western Cape.  We are inviting you to participate in this research project because you are 
working with adolescents who are HIV positive and on antiretroviral treatment and you are 
considered to be very knowledgeable on the subject matter and will be able to provide the 
researcher with useful insights. The purpose of this research project is to try and identify what 
are the reasons or circumstances for adolescents to not remain compliant on their ARTs. We 
are hoping that if we have this information that assistance can be provided to patients and 
staff members to enable better compliance to medication. 
What will I be asked to do if I agree to participate? 
You will be asked to participate in a one-on-one interview with the researcher and a translator 
if required. If you wish to participate in the study you will be asked to sign a consent form. 
The interview will last approximately 20 minutes. You will be asked about your experiences 
in working with HIV positive adolescents on antiretroviral treatment. The interviews will be 
conducted in a quiet room at the clinic at a time that suits you best.  
Would my participation in this study be kept confidential? 
The researcher undertakes to protect your identity and the nature of your contribution at all 
times.  
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What are the risks of this research? 
There may be some risks from participating in this research study. All human interactions and 
talking about self or others carry some amount of risks. We will nevertheless minimise such 
risks and act promptly to assist you if you experience any discomfort, psychological or 
otherwise during the process of your participation in this study. Where necessary, an 
appropriate referral will be made to a suitable professional for further assistance or 
intervention.   
What are the benefits of this research? 
The results may help the investigator learn more about ART non-compliance and what leads 
to this problem. We hope that, in the future, other people might also benefit from this study 
through improved understanding of these issues.  
Do I have to be in this research and may I stop participating at any time?   
Your participation in this research is completely voluntary.  You may choose not to take part 
at all. If you decide to participate in this research, you may stop participating at any time.  If 
you decide not to participate in this study or if you stop participating at any time, you will not 
be penalized or lose any benefits to which you otherwise qualify.  
What if I have questions? 
This research is being conducted by Lee-Ann Davids, a Masters student at the School of 
Public Health at the University of the Western Cape.  If you have any questions about the 
research study itself, please contact Lee-Ann Davids at +27722333877 or 9 Melina Street, 
Rosendal, Durbanville, 7550. Alternatively send an email to 3409645@myuwc.ac.za 
Should you have any questions regarding this study and your rights as a research participant 
or if you wish to report any problems you have experienced related to the study, please 
contact:  
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Prof Helen Schneider 
School of Public Health  
Head of Department 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
soph-comm@uwc.ac.za     
 
Prof José Frantz  
Dean of the Faculty of Community and Health Sciences  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za     
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Appendix D: Assent form 
University of the Western Cape                     
School of Public Health 
 
 
ASSENT FORM 
Title of Research Project: Adherence to antiretroviral treatment amongst adolescents in a 
low socio-economic urban setting in Cape Town, South Africa. 
The study has been described to me in language that I understand. My questions about the 
study have been answered. I understand what my participation will involve and I agree to 
participate of my own choice and free will.  I understand that my identity will not be 
disclosed to anyone. I understand that I may withdraw from the study at any time without 
giving a reason and without fear of negative consequences or loss of benefits.    
This research project involves making audiotapes of the focus group discussions and one-on- 
one interviews. An audio tape will enable the researcher to record the information and 
transcribe it later which entails listening to the recording and typing out every word. This is 
being done because it will be very difficult to write down everything as the discussions are 
taking place. The audio tapes will be stored in a locked cupboard and only the researcher will 
have a key.  
 
___   I agree to be audiotaped during my participation in this study. 
___   I do not agree to be audiotaped during my participation in this study. 
 
 
Participant’s signature……………………………….        
Date……………………… 
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Appendix E: Consent form 
University of the Western Cape 
School of Public Health 
 
CONSENT FORM 
Title of Research Project: Adherence to antiretroviral treatment amongst adolescents in a 
low socio-economic urban setting in Cape Town, South Africa. 
The study has been described to me in language that I understand. My questions about the 
study have been answered. I understand what my participation will involve and I agree to 
participate of my own choice and free will.  I understand that my identity will not be 
disclosed to anyone. I understand that I may withdraw from the study at any time without 
giving a reason and without fear of negative consequences or loss of benefits.    
This research project involves making audiotapes of the focus group discussions and one-on- 
one interviews. An audio tape will enable the researcher to record the information and 
transcribe it later which entails listening to the recording and typing out every word. This is 
being done because it will be very difficult to write down everything as the discussions are 
taking place. The audio tapes will be stored in a locked cupboard and only the researcher will 
have a key.  
 
___   I agree to be audiotaped during my participation in this study. 
___   I do not agree to be audiotaped during my participation in this study. 
 
Participant’s signature……………………………….        
Parents signature (if participant is <18years old)………………………………     
Date……………………… 
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Appendix F: Consent form for key informants 
University of the Western Cape 
School of Public Health 
 
CONSENT FORM FOR KEY INFORMANTS 
Title of Research Project: Adherence to antiretroviral treatment amongst adolescents in a 
low socio-economic urban setting in Cape Town, South Africa. 
The study has been described to me in language that I understand. My questions about the 
study have been answered. I understand what my participation will involve and I agree to 
participate of my own choice and free will.  I understand that my identity will not be 
disclosed to anyone. I understand that I may withdraw from the study at any time without 
giving a reason and without fear of negative consequences or loss of benefits.    
This research project involves making audiotapes of the interview. An audio tape will enable 
the researcher to record the information and transcribe it later which entails listening to the 
recording and typing out every word. This is being done because it will be very difficult to 
write down everything as the discussion is taking place. The audio tapes will be stored in a 
locked cupboard and only the researcher will have a key.  
 
___   I agree to be audiotaped during my participation in this study. 
___   I do not agree to be audiotaped during my participation in this study. 
 
Participant’s signature……………………………….        
Date……………………… 
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Appendix G: Focus group confidentiality binding form 
University of the Western Cape 
School of Public Health 
 
FOCUS GROUP CONFIDENTIALITY BINDING FORM 
Title of Research Project: Adherence to antiretroviral treatment amongst adolescents in a 
low socio-economic urban setting in Cape Town, South Africa. 
The study has been described to me in language that I understand. My questions about the 
study have been answered. I understand what my participation will involve and I agree to 
participate of my own choice and free will.  I understand that my identity will not be 
disclosed to anyone by the researchers. I understand that I may withdraw from the study at 
any time without giving a reason and without fear of negative consequences or loss of 
benefits. I understand that confidentiality is dependent on participants’ in the Focus Group 
maintaining confidentiality.  
I hereby agree to uphold the confidentiality of the discussions in the focus group by not 
disclosing the identity of other participants or any aspects of their contributions to members 
outside of the group. 
 
 
Participant’s name……………………………………….. 
Participant’s signature…………………………………..             
Date……………………… 
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Appendix H: Focus group discussion question guide 
University of the Western Cape 
School of Public Health 
 
FOCUS GROUP DISCUSSION QUESTION GUIDE 
Question 1 
Could you tell me how your financial situation and schooling impacts on you taking your 
medication? 
Prompts: 
Do you have enough time after school to access the clinic? 
Is the clinic accessible after school? 
Do you feel comfortable telling your teachers that you need to go to the clinic to get 
medication? 
How does your employment routine and relationship with your employer influence if you go 
to collect medication? 
How does your financial situation and family relationships impact on whether you collect and 
take your treatment? 
 
Question 2 
Tell me a bit about your relationship with the clinic and clinic staff? 
Prompts 
What do you like and dislike about the clinic and staff members? 
What sort of support (if any) do you receive from the clinic and staff members? 
Do you feel the clinic encourages you to take your medication? 
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What about the clinic and the staff do you think will motivate you to take your treatment? 
 
Question 3 
Can you tell me about your experience with taking your pills? 
Prompts 
How do your tablets make you feel? 
What helps you to remember to take your pills? 
Why do you sometimes forget to take your pills? 
Have your pills ever made you feel sick and what do you do if that happens? 
Do you sometimes feel you are taking too many pills? 
 
Question 4 
What are the good factors about yourself that helps you to take your meds? 
What do you think are bad things about yourself and your life that causes you to forget to 
take your meds? 
Prompts 
Tell me about what you and your friends do over the weekends?  
Drugs. Alcohol. Excessive partying. 
 
Question 5 
How do you think speaking about your HIV status helps you to take your medication? 
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Prompts 
Does your family encourage you to speak about your status? 
Do you have a best friend? 
Are you shy/ embarrassed about your status? 
 
Question 6 
How do you think your mood influences whether you take your medication? 
 
Prompts 
Are you sometimes sad when you have to take your medication? 
Do you prefer taking your medication when you are happy or sad? 
How do you feel about your treatment? 
 
Question 7 
Do you think the treatment can improve your health? 
Question 8 
What do you think about having a “boyfriend” or “girlfriend”? 
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Appendix I: Individual in-depth interview guide 
University of the Western Cape 
School of Public Health 
  
 
INDIVIDUAL IN-DEPTH INTERVIEW GUIDE 
Explain to me how attending school and school commitments influences your clinic 
attendance and taking ART. 
What are the issues at home and in your family that makes it difficult for you to take your 
treatment and come to the clinic? 
Please explain how finances influences the way you take your treatment. 
Please elaborate on your relationship with the clinic and the clinic staff. 
How do you feel about the fact that you have to take treatment on a daily basis? 
How do you feel about having a boyfriend or girlfriend? 
What are the things which make it difficult for you take your ART? 
What are the things which encourage you to take your ART? 
How do you feel about telling your friends or family about your HIV status? 
What effect do you think the treatment has on your body? 
What are your plans for the future? 
What do you do on the weekends?  
Have you noticed if there are certain times in the day/week/year when it is difficult to take 
your treatment? 
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Appendix J: Key-informant interview guide 
University of the Western Cape 
School of Public Health 
 
KEY-INFORMANT INTERVIEW GUIDE 
Tell me about your experience with managing adolescents 
Do you enjoy it: why or why not? 
How do you think the adolescents’ socio-economic situation influences their adherence to 
ARTs? 
What do you think of the health-system set-up in order to cater for adolescents? 
How do you think therapy side-effects influences adherence if at all? 
How do you think patient-related factors influences adherence: age; substances; 
psychological issues;  
Are a lot of the adolescents supported by their parents/family/guardians in this clinic? Do you 
think that influences adherence? 
In your experience, is there a difference in the reasons offered by adolescents for non 
adherence vs. adults 
Do you think adolescents on ARTs should be managed differently than adults? 
How do you think disclosure impacts on adherence? 
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Appendix K: Ethics clearance from UWC 
 
UNIVERSITY OF THE WESTERN CAPE 
 
DEPARTMENT OF RESEARCH DEVELOPMENT 
 
 
 
 
 
18 January 2016 
 
 
To Whom It May Concern 
 
 
I hereby certify that the Senate Research Committee of the University of the Western 
Cape approved the methodology and ethics of the following research project by:  
Ms L-A Davids (School of Public Health) 
 
Research Project: Adherence to anti-retroviral treatment amongst adolescents  in  a  low  
socio-economic  urban setting in Cape Town, South Africa. 
 
Registration no: 15/7/254 
 
 
Any amendments, extension or other modifications to the protocol must be submitted to the 
Ethics Committee for approval. 
 
 
The Committee must be informed of any serious adverse event and/or termination of the 
study. 
 
 
 
 
 
Ms Patricia Josias 
Research Ethics Committee Officer  
University of the Western Cape 
 
 
 
 
Private Bag X17, Bellville 7535, South Africa  
T: +27 21 959 2988/2948. F: +27 21 959 3170  
E: pjosias@uwc.ac.za  
www.uwc.ac.za 
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Appendix L: Ethics clearance from City of Cape Town Municipality 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
